National Instruments (NATI) 10-Q 28 Oct 22 2022 Q3 Quarterly report Financial data

Cover

Cover - shares	9 Months Ended
	Sep. 30, 2022	Oct. 24, 2022
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Sep. 30, 2022
Document Transition Report	false
Entity File Number	000-25426
Entity Registrant Name	NATIONAL INSTRUMENTS CORP
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	74-1871327
Entity Address, Address Line One	11500 North MoPac Expressway
Entity Address, City or Town	Austin,
Entity Address, State or Province	TX
Entity Address, Postal Zip Code	78759
City Area Code	512
Local Phone Number	683-0100
Title of 12(b) Security	Common Stock, $0.01 par value
Trading Symbol	NATI
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding (in shares)		130,568,539
Entity Central Index Key	0000935494
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2022
Document Fiscal Period Focus	Q3
Amendment Flag	false

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Assets
Cash and cash equivalents	$ 149,002	$ 211,106
Accounts receivable, net	380,792	341,275
Inventories, net	373,544	289,243
Prepaid expenses and other current assets	144,145	89,925
Total current assets	1,047,483	931,549
Property and equipment, net	254,127	253,668
Goodwill	593,148	575,992
Intangible assets, net	219,730	220,418
Operating lease right-of-use assets	59,906	58,641
Other long-term assets	71,140	74,717
Total assets	2,245,534	2,114,985
Liabilities and stockholders' equity
Accounts payable and accrued expenses	96,848	83,218
Accrued compensation	61,166	111,261
Deferred revenue - current	118,257	137,818
Operating lease liabilities - current	13,288	13,137
Other taxes payable	61,002	59,109
Debt, current	25,000	0
Other current liabilities	52,079	40,671
Total current liabilities	427,640	445,214
Deferred income taxes	13,725	14,249
Income tax payable - non-current	40,646	54,195
Deferred revenue - non-current	50,177	32,822
Operating lease liabilities - non-current	32,027	30,468
Debt, non-current	542,768	300,000
Other long-term liabilities	15,066	14,340
Total liabilities	1,122,049	891,288
Commitments and contingencies
Stockholders' equity:
Preferred stock:  par value $0.01;  5,000,000 shares authorized; none issued and outstanding	0	0
Common stock:  par value $0.01;  360,000,000 shares authorized; 130,568,539 shares and 132,293,898 shares issued and outstanding, respectively	1,306	1,323
Additional paid-in capital	1,183,329	1,129,647
Retained (deficit) earnings	(18,135)	112,858
Accumulated other comprehensive loss	(43,015)	(20,131)
Total stockholders’ equity	1,123,485	1,223,697
Total liabilities and stockholders’ equity	$ 2,245,534	$ 2,114,985

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares	Sep. 30, 2022	Dec. 31, 2021
Statement of Financial Position [Abstract]
Preferred stock, par value per share (in usd per share)	$ 0.01	$ 0.01
Preferred stock, authorized (in shares)	5,000,000	5,000,000
Preferred stock, issued (in shares)	0	0
Preferred stock, outstanding (in shares)	0	0
Common stock, par value per share (in usd per share)	$ 0.01	$ 0.01
Common stock, authorized (in shares)	360,000,000	360,000,000
Common stock, issued (in shares)	130,568,539	132,293,898
Common stock, outstanding (in shares)	130,568,539	132,293,898

Condensed Consolidated Statemen

Condensed Consolidated Statements Of Income - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Net sales:
Total net sales	$ 427,928	$ 367,162	$ 1,208,699	$ 1,049,040
Cost of sales:
Total cost of sales	143,702	102,715	390,403	297,367
Gross profit	284,226	264,447	818,296	751,673
Operating expenses:
Sales and marketing	119,951	117,065	365,015	345,048
Research and development	82,861	82,165	250,610	243,685
General and administrative	34,617	31,037	104,569	94,672
Total operating expenses	237,429	230,267	720,194	683,405
Gain on sale of assets	33,636	0	33,636	0
Operating income	80,433	34,180	131,738	68,268
Other expense	(5,150)	(1,820)	(8,622)	(9,851)
Income before income taxes	75,283	32,360	123,116	58,417
Provision for income taxes	13,376	5,183	23,539	9,438
Net income	$ 61,907	$ 27,177	$ 99,577	$ 48,979
Basic earnings per share (in usd per share)	$ 0.47	$ 0.20	$ 0.75	$ 0.37
Weighted average shares outstanding - basic (in shares)	132,044	133,031	132,040	132,657
Diluted earnings per share (in usd per share)	$ 0.47	$ 0.20	$ 0.75	$ 0.37
Weighted average shares outstanding - diluted (in shares)	132,581	133,686	133,001	133,829
Dividends declared per share (in usd per share)	$ 0.28	$ 0.27	$ 0.84	$ 0.81
Product
Net sales:
Total net sales	$ 389,620	$ 325,724	$ 1,088,110	$ 927,307
Cost of sales:
Total cost of sales	139,823	99,072	378,154	286,485
Software maintenance
Net sales:
Total net sales	38,308	41,438	120,589	121,733
Cost of sales:
Total cost of sales	$ 3,879	$ 3,643	$ 12,249	$ 10,882

Condensed Consolidated Statem_2

Condensed Consolidated Statements Of Comprehensive Income - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Statement of Comprehensive Income [Abstract]
Net income	$ 61,907	$ 27,177	$ 99,577	$ 48,979
Other comprehensive (loss) income, before tax and net of reclassification adjustments:
Foreign currency translation adjustment	(18,563)	(5,675)	(32,009)	(10,585)
Unrealized loss on securities available-for-sale	0	(21)	0	(162)
Unrealized gain on derivative instruments	3,960	4,243	11,987	18,605
Other comprehensive (loss) income, before tax	(14,603)	(1,453)	(20,022)	7,858
Tax expense related to items of other comprehensive income	932	948	2,862	4,208
Other comprehensive (loss) income, net of tax	(15,535)	(2,401)	(22,884)	3,650
Comprehensive income	$ 46,372	$ 24,776	$ 76,693	$ 52,629

Condensed Consolidated Statem_3

Condensed Consolidated Statements Of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Cash flow from operating activities:
Net income	$ 99,577	$ 48,979
Adjustments to reconcile net income to net cash provided by operating activities:
Gain on sale of assets	(33,636)	0
Depreciation and amortization	68,828	73,418
Stock-based compensation	60,843	56,064
(Gain) loss from equity-method investees	(483)	5,082
Deferred income taxes	928	(2,030)
Changes in operating assets and liabilities	(204,987)	(95,477)
Net cash (used in) provided by operating activities	(8,930)	86,036
Cash flow from investing activities:
Acquisitions, net of cash received	(72,802)	(19,784)
Capital expenditures	(39,193)	(26,147)
Proceeds from sale of assets	40,987	0
Capitalization of internally developed software	(388)	(1,246)
Additions to other intangibles	(3,165)	(2,317)
Payments to acquire equity-method investments	0	(15,753)
Sales and maturities of short-term investments	0	59,714
Net cash used in investing activities	(74,561)	(5,533)
Cash flow from financing activities:
Proceeds from revolving line of credit	268,000	100,000
Principal payments on revolving line of credit	(498,000)	0
Proceeds from term loan	500,000	0
Payments on term loan	0	(98,750)
Debt issuance costs	(2,348)	(1,993)
Proceeds from issuance of common stock	25,444	25,438
Repurchase of common stock	(151,831)	(25,000)
Dividends paid	(111,161)	(107,397)
Net cash provided by (used in) financing activities	30,104	(107,702)
Effect of exchange rate changes on cash	(8,717)	(2,336)
Net change in cash and cash equivalents	(62,104)	(29,535)
Cash and cash equivalents at beginning of period	211,106	260,232
Cash and cash equivalents at end of period	$ 149,002	$ 230,697

Condensed Consolidated Statem_4

Condensed Consolidated Statements Of Stockholders' Equity - USD ($) $ in Thousands		Total	Common Stock	Additional-Paid in Capital	Retained Earnings/(Deficit)	Accumulated Other Comprehensive Loss
Beginning Balance (in shares) at Dec. 31, 2020			131,246,615
Beginning Balance at Dec. 31, 2020		$ 1,224,871	$ 1,312	$ 1,033,284	$ 211,101	$ (20,826)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income		48,979			48,979
Other comprehensive (loss) gain, net of tax		3,650				3,650
Issuance of common stock under employee plans (in shares)			1,974,685
Issuance of common stock under employee plans		25,438	$ 20	25,418
Stock-based compensation		55,931		55,931
Repurchase of common stock (in shares)			(599,066)
Repurchase of common stock		(25,000)	$ (6)	(4,715)	(20,279)
Dividends paid	[1]	(107,397)			(107,397)
Ending Balance (in shares) at Sep. 30, 2021			132,622,234
Ending Balance at Sep. 30, 2021		1,226,472	$ 1,326	1,109,918	132,404	(17,176)
Beginning Balance (in shares) at Jun. 30, 2021			132,980,932
Beginning Balance at Jun. 30, 2021		1,235,652	$ 1,330	1,087,622	161,475	(14,775)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income		27,177			27,177
Other comprehensive (loss) gain, net of tax		(2,401)				(2,401)
Issuance of common stock under employee plans (in shares)			240,368
Issuance of common stock under employee plans		8,199	$ 2	8,197
Stock-based compensation		18,814		18,814
Repurchase of common stock (in shares)			(599,066)
Repurchase of common stock		(25,000)	$ (6)	(4,715)	(20,279)
Dividends paid	[1]	(35,969)			(35,969)
Ending Balance (in shares) at Sep. 30, 2021			132,622,234
Ending Balance at Sep. 30, 2021		$ 1,226,472	$ 1,326	1,109,918	132,404	(17,176)
Beginning Balance (in shares) at Dec. 31, 2021		132,293,898	132,293,898
Beginning Balance at Dec. 31, 2021		$ 1,223,697	$ 1,323	1,129,647	112,858	(20,131)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income		99,577			99,577
Other comprehensive (loss) gain, net of tax		(22,884)				(22,884)
Issuance of common stock under employee plans (in shares)			2,066,704
Issuance of common stock under employee plans		25,444	$ 21	25,423
Stock-based compensation		60,643		60,643
Repurchase of common stock (in shares)			(3,792,063)
Repurchase of common stock		(151,831)	$ (38)	(32,384)	(119,409)
Dividends paid	[2]	$ (111,161)			(111,161)
Ending Balance (in shares) at Sep. 30, 2022		130,568,539	130,568,539
Ending Balance at Sep. 30, 2022		$ 1,123,485	$ 1,306	1,183,329	(18,135)	(43,015)
Beginning Balance (in shares) at Jun. 30, 2022			132,316,344
Beginning Balance at Jun. 30, 2022		1,168,507	$ 1,323	1,173,131	21,533	(27,480)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income		61,907			61,907
Other comprehensive (loss) gain, net of tax		(15,535)				(15,535)
Issuance of common stock under employee plans (in shares)			285,330
Issuance of common stock under employee plans		7,585	$ 3	7,582
Stock-based compensation		19,979		19,979
Repurchase of common stock (in shares)			(2,033,135)
Repurchase of common stock		(81,830)	$ (20)	(17,363)	(64,447)
Dividends paid	[2]	$ (37,128)			(37,128)
Ending Balance (in shares) at Sep. 30, 2022		130,568,539	130,568,539
Ending Balance at Sep. 30, 2022		$ 1,123,485	$ 1,306	$ 1,183,329	$ (18,135)	$ (43,015)
[1]Cash dividends declared per share of common stock were $0.27 for the three months ended September 30, 2021, and $0.81 for the nine months ended September 30, 2021.[2]Cash dividends declared per share of common stock were $0.28 for the three months ended September 30, 2022, and $0.84 for the nine months ended September 30, 2022.

Condensed Consolidated Statem_5

Condensed Consolidated Statements Of Stockholders' Equity (Parenthetical) - $ / shares	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Statement of Stockholders' Equity [Abstract]
Dividends declared per share (in usd per share)	$ 0.28	$ 0.27	$ 0.84	$ 0.81

Basis of presentation

Basis of presentation	9 Months Ended
	Sep. 30, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis of presentation	Basis of presentation The accompanying unaudited consolidated financial statements should be read in conjunction with the consolidated financial statements and notes thereto for the fiscal year ended December 31, 2021, included in our Annual Report on Form 10-K filed with the Securities and Exchange Commission ("SEC") on February 22, 2022 (the "Form 10-K"). In our opinion, the accompanying consolidated financial statements reflect all adjustments (consisting only of normal recurring items) considered necessary to state fairly our financial position at September 30, 2022 and December 31, 2021, the results of our operations and comprehensive income for the three and nine months ended September 30, 2022 and 2021, our cash flows for the nine months ended September 30, 2022 and 2021 and our statement of stockholders' equity for the three and nine months ended September 30, 2022 and 2021. Our operating results for the three and nine months ended September 30, 2022 are not necessarily indicative of the results that may be expected for the year ending December 31, 2022. These financial statements have been prepared in accordance with accounting principles generally accepted in the United States. Gain on Sale of Assets During the three months ended September 30, 2022, we recognized a gain of $33.6 million from the sale of approximately 75-acres of land in Williamson County, Texas and two office buildings in Aachen, Germany. The buildings in Germany were previously used for certain research and development activities that have been relocated to other research and development locations. The disposal gain is presented as “Gain on sale of assets” in the Consolidated Statements of Income. Recent Accounting Pronouncements In October 2021, the Financial Accounting Standards Board ("FASB") issued ASU No. 2021-08—Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers. The new guidance requires contract assets and contract liabilities acquired in a business combination to be recognized in accordance with ASC Topic 606 as if the acquirer had originated the contracts. We early adopted the standard on January 1, 2022. The adoption of this accounting standard update did not have a material effect on our consolidated financial statements and related disclosures. In November 2021, the FASB issued Accounting Standards Update ("ASU") No. 2021-10- Government Assistance, to increase transparency of government assistance including the disclosure of (1) the types of assistance, (2) an entity’s accounting for the assistance, and (3) the effect of the assistance on an entity’s financial statements. ASU 2021-10 is effective for annual periods beginning after December 15, 2021. Early adoption is permitted. We are currently evaluating the impact of this accounting standard update on our annual financial statement disclosures. In September 2022, the FASB issued ASU No. 2022-04-Supplier Finance Programs (Subtopic 405-50): Disclosure of Supplier Finance Program Obligations. The amendments in Update 2022-04 require that a buyer in a supplier finance program disclose sufficient information about the program to allow a user of financial statements to understand the program’s nature, activity during the period, changes from period to period, and potential magnitude. The amendments in this Update do not affect the recognition, measurement, or financial statement presentation of obligations covered by supplier finance programs. The amendments in this Update are effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years, except for the amendment on rollforward information, which is effective for fiscal years beginning after December 15, 2023. Early adoption is permitted. We are currently evaluating the impact of this accounting standard update on our annual financial statement disclosures. Although there are several other accounting pronouncements recently issued by the FASB, we do not expect the adoption of any of these accounting pronouncements to have material impact on our consolidated financial statements. Summary of Significant Accounting Policies There were no material changes to our significant accounting policies during the three and nine months ended September 30, 2022 compared to the significant accounting policies described in our Form 10-K. Other (Expense) Income Other (expense) income, net consisted of the following amounts: Three Months Ended September 30, Nine Months Ended September 30, (In thousands) (Unaudited) (Unaudited) 2022 2021 2022 2021 Interest income $ 103 $ 56 $ 207 $ 330 Interest expense (4,851) (657) (8,643) (2,584) Gain (Loss) from equity-method investments 353 278 483 (5,082) Net foreign exchange loss (3,625) (1,226) (5,560) (2,681) Other gain (loss) 2,870 (271) 4,891 166 Other expense, net $ (5,150) $ (1,820) $ (8,622) $ (9,851) Other Current Liabilities Other current liabilities on our consolidated balance sheet includes the following amounts (in thousands): As of September 30, 2022 As of December 31, (unaudited) 2021 Income taxes payable - current $ 17,211 $ 14,457 Hedge payable - current 10,833 7,091 Employer social security taxes - current — 5,785 Other 24,035 13,338 Total $ 52,079 $ 40,671 Earnings Per Share Basic earnings per share (“EPS”) is computed by dividing net income by the weighted average number of common shares outstanding during each period. Diluted EPS is computed by dividing net income by the weighted average number of common shares and common share equivalents outstanding (if dilutive) during each period. The number of common share equivalents, which includes restricted stock units ("RSUs"), is computed using the treasury stock method. The reconciliation of the denominators used to calculate basic EPS and diluted EPS for the three and nine months ended September 30, 2022 and 2021 are as follows (in thousands): Three Months Ended September 30, Nine Months Ended September 30, (Unaudited) (Unaudited) 2022 2021 2022 2021 Weighted average shares outstanding-basic 132,044 133,031 132,040 132,657 Plus: Common share equivalents RSUs 537 655 961 1,172 Weighted average shares outstanding-diluted 132,581 133,686 133,001 133,829 Shares issuable upon vesting of RSU awards of 1,048,000 shares and 143,000 shares for the three months ended September 30, 2022 and 2021, respectively, and 400,000 shares and 123,000 shares for the nine months ended September 30, 2022 and 2021, respectively, were excluded in the computations of diluted EPS because the effect of including the stock awards would have been anti-dilutive.

Revenue

Revenue	9 Months Ended
	Sep. 30, 2022
Revenue from Contract with Customer [Abstract]
Revenue	Revenue Revenue Recognition Revenue is recognized upon transfer of control of the promised products or services to customers in an amount that reflects the consideration we expect to receive in exchange for those products or services. We enter into contracts that can include various combinations of our products or services, which are generally capable of being distinct and accounted for as separate performance obligations. Revenue is recognized net of allowances for returns and any taxes collected from customers, which are subsequently remitted to governmental authorities. Disaggregation of Revenues We disaggregate revenue from contracts with customers based on the timing of transfer of goods or services to customers (point-in-time or over time), geographic region based on the billing location of the customer and customer industry grouping. Total net sales based on the timing of transfer of goods or services to customers and geographic region are as follows: Three Months Ended September 30, (Unaudited) 2022 2021 (In thousands) Net sales: Point-in-Time (1) Over Time Total Point-in-Time (1) Over Time Total Americas $ 166,318 $ 26,643 $ 192,961 $ 125,069 $ 23,835 $ 148,904 EMEA 91,249 19,087 110,336 72,430 22,433 94,863 APAC 114,100 10,531 124,631 112,931 10,464 123,395 Total net sales (1) $ 371,667 $ 56,261 $ 427,928 $ 310,430 $ 56,732 $ 367,162 (1) Net sales contain s hedging gains and losses, which do not represent revenues recognized from customers. See Note 5 - Derivative instruments and hedging activities of Notes to Consolidated Financial Statements for more information on the impact of our hedging activities on our results of operations. Nine Months Ended September 30, (Unaudited) 2022 2021 (In thousands) Net sales: Point-in-Time (1) Over Time Total Point-in-Time (1) Over Time Total Americas $ 432,402 $ 78,946 $ 511,348 $ 341,870 $ 68,436 $ 410,306 EMEA 247,687 60,807 308,494 204,786 64,769 269,555 APAC 357,088 31,769 388,857 337,455 31,724 369,179 Total net sales (1) $ 1,037,177 $ 171,522 $ 1,208,699 $ 884,111 $ 164,929 $ 1,049,040 (1) Net sales contains hedging gains and losses, which do not represent revenues recognized from customers. The industry grouping used to disaggregate net sales is determined at the customer account level. Accounts assigned to one of our three industry-specific groupings are either designated as Semiconductor and Electronics, Transportation, or Aerospace, Defense and Government. We are able to leverage the investments in these areas to also serve a broad base of diverse customers in the other industries we serve, which are included in our Portfolio grouping. Our recent acquisitions described in Note 16 are presented within the "Transportation" industry grouping below. Three Months Ended September 30, Nine Months Ended September 30, (In thousands) (Unaudited) Industry Grouping 2022 2021 2022 2021 Semiconductor & Electronics 101,678 93,892 320,920 292,114 Transportation 83,692 52,954 212,471 149,410 Aerospace, Defense & Government 104,641 92,646 297,569 256,211 Portfolio 137,917 127,670 377,739 351,305 Total net sales $ 427,928 $ 367,162 $ 1,208,699 $ 1,049,040 Information about Contract Balances Amounts billed in advance of services being provided are typically accounted for as deferred revenue. Nearly all of our deferred revenue balance is related to extended hardware and software maintenance contracts. Payment terms and conditions vary by contract type, although payment is typically due within 30 to 90 days of contract inception. In instances where the timing of revenue recognition differs from the timing of invoicing, we have determined our contracts generally do not include a significant financing component. The primary purpose of our invoicing terms is to provide customers with simplified and predictable ways of purchasing our products and services, not to receive financing from our customers, such as invoicing at the beginning of a subscription term with a portion of the revenue recognized ratably over the contract period, or to provide customers with financing, such as multi-year on-premises licenses that are invoiced annually with revenue recognized upfront. Changes in deferred revenue, current and non-current, during the nine months ended September 30, 2022 were as follows: (In thousands) Amount Balance as of December 31, 2021 $ 170,640 Deferral of revenue billed in current period, net of recognition 130,948 Recognition of revenue deferred in prior periods (118,902) Foreign currency translation impact (14,252) Balance as of September 30, 2022 (unaudited) $ 168,434 For the nine months ended September 30, 2022, revenue recognized from performance obligations satisfied in prior periods (for example, due to changes in transaction price) was not material. Amounts recognized as revenue in excess of amounts billed are recorded as unbilled receivables. Unbilled receivables which are anticipated to be invoiced in the next twelve months are included in "Other current assets" on the consolidated balance sheet. Based on the nature of our contracts with customers, we do not typically recognize unbilled receivables related to revenues recognized in excess of amounts billed. For the nine months ended September 30, 2022 and December 31, 2021, the amounts recorded that were related to unbilled receivables were not material. Unsatisfied Performance Obligations Revenue expected to be recognized in any future period related to remaining performance obligations, excluding revenue pertaining to contracts that have an original expected duration of one year or less and contracts where revenue is recognized as invoiced, was approximately $94 million as of September 30, 2022. Because we typically invoice customers at contract inception, this amount is included in our current and non-current deferred revenue balances and primarily relates to multi-year payments for hardware service and software service offerings. As of September 30, 2022, we expect to recognize approximately 12% of the revenue related to these unsatisfied performance obligations during the remainder of 2022, 42% during 2023, and 46% thereafter. Assets Recognized from the Costs to Obtain a Contract with a Customer We recognize an asset for the incremental costs of obtaining a contract with a customer if we expect the benefit of those costs to be longer than one year. We have determined that certain sales incentive programs meet the requirements to be capitalized. Capitalized incremental costs related to initial contracts and renewals are amortized over the same period because the commissions paid on both the initial contract and renewals are commensurate with one another. Total capitalized costs to

Investments

Investments	9 Months Ended
	Sep. 30, 2022
Cash, Cash Equivalents, and Short-Term Investments [Abstract]
Investments	Investments Equity-Method Investments The carrying value of our equity method investments was $28 million and $32 million as of September 30, 2022 and December 31, 2021, respectively. During the three months ended September 30, 2022 and 2021, net sales to our equity-method investees were approximately $1.5 million and $0.9 million, respectively. During the nine months ended September 30, 2022 and 2021, net sales to our equity-method investees were approximately $4.3 million and $2.5 million, respectively. During the three and nine months ended September 30, 2022 and 2021, purchases from our equity-method investees were not material. We recorded a $3.5 million impairment loss related to an equity-method investment during the three months ended March 31, 2021. Our proportionate share of the income/(loss) from equity-method investments is included within "Other expense". Refer to Note 1 - Basis of Presentation of Notes to Consolidated Financial Statements for additional information on these amounts for the three and nine months ended September 30, 2022 and 2021.

Fair value measurements

Fair value measurements	9 Months Ended
	Sep. 30, 2022
Fair Value Disclosures [Abstract]
Fair value measurements	Fair value measurements We define fair value to be the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When determining the fair value measurements for assets and liabilities required or permitted to be recorded at fair value, we consider the principal or most advantageous market that market participants may use when pricing the asset or liability. We follow a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. Fair value measurement is determined based on the lowest level input that is significant to the fair value measurement. The three values of the fair value hierarchy are the following: Level 1 – Quoted prices in active markets for identical assets or liabilities Level 2 – Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly Level 3 – Inputs that are not based on observable market data Assets and liabilities measured at fair value on a recurring basis are summarized below: Fair Value Measurements at Reporting Date Using (In thousands) (Unaudited) Description September 30, 2022 Level 1 Level 2 Level 3 Assets Other assets: Derivatives 30,275 — 30,275 — Total Assets $ 30,275 $ — $ 30,275 $ — Liabilities Derivatives $ (11,624) $ — $ (11,624) $ — Total Liabilities $ (11,624) $ — $ (11,624) $ — (In thousands) Fair Value Measurements at Reporting Date Using Description December 31, 2021 Level 1 Level 2 Level 3 Assets Cash and cash equivalents: Money market funds $ 101,290 $ 101,290 $ — $ — Other assets: Derivatives 12,407 — 12,407 — Total Assets $ 113,697 $ 101,290 $ 12,407 $ — Liabilities Derivatives $ (9,468) $ — $ (9,468) $ — Total Liabilities $ (9,468) $ — $ (9,468) $ — We value our available-for-sale short-term investments and cash equivalents based on pricing from third party pricing vendors, who may use quoted prices in active markets for identical assets (Level 1 inputs) or inputs other than quoted prices that are observable either directly or indirectly (Level 2 inputs) in determining fair value. We classify all of our fixed income available-for-sale securities as having Level 2 inputs. The valuation techniques used to measure the fair value of our financial instruments having Level 2 inputs were derived from non-binding market consensus prices that are corroborated by observable market data, quoted market prices for similar instruments, or pricing models, such as discounted cash flow techniques. We believe all of these sources reflect the credit risk associated with each of our available-for-sale short-term investments. Short-term investments available-for-sale typically consist of debt securities issued by states of the U.S. and political subdivisions of the U.S., corporate debt securities and debt securities issued by U.S. government organizations and agencies. We did not have any short-term investments as of December 31, 2021 or September 30, 2022. Derivatives include foreign currency forward contracts. Our foreign currency forward contracts are valued using an income approach (Level 2) based on the spot rate less the contract rate multiplied by the notional amount. We consider counterparty credit risk in the valuation of our derivatives. However, counterparty credit risk did not impact the valuation of our derivatives during the nine months ended September 30, 2022. There were no transfers in or out of Level 1 or Level 2 during the nine months ended September 30, 2022. We did not have any items that were measured at fair value on a nonrecurring basis at September 30, 2022 and December 31, 2021. The carrying value of net accounts receivable, accounts payable, and long-term debt contained in the consolidated balance sheets approximates fair value.

Derivative instruments and hedg

Derivative instruments and hedging activities	9 Months Ended
	Sep. 30, 2022
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivative instruments and hedging activities	Derivative instruments and hedging activities We recognize all of our derivative instruments as either assets or liabilities in our statement of financial position at fair value. The accounting for changes in the fair value (i.e., gains or losses) of a derivative instrument depends on whether it has been designated and qualifies as part of a hedging relationship and further, on the type of hedging relationship. For those derivative instruments that are designated and qualify as hedging instruments, we designate the hedging instrument, based upon the exposure being hedged, as a fair value hedge, cash flow hedge, or a hedge of a net investment in a foreign operation. We have direct operations in approximately 40 countries. Sales outside of the Americas accounted for approximately 55% and 59% of our net sales during the three months ended September 30, 2022 and 2021, respectively, and approximately 58% and 61% during the nine months ended September 30, 2022 and 2021, respectively. Our activities expose us to a variety of market risks, including the effects of changes in foreign currency exchange rates. These financial risks are monitored and managed by us as an integral part of our overall risk management program. We maintain a foreign currency risk management strategy that uses derivative instruments (foreign currency forward contracts) to help protect our earnings and cash flows from fluctuations caused by the volatility in currency exchange rates. Movements in foreign currency exchange rates pose a risk to our operations and competitive position, in that exchange rate changes may affect our profitability and cash flow, and the business or pricing strategies of our non-U.S. based competitors. The vast majority of our foreign sales are denominated in the customers’ local currency. We use foreign currency forward contracts as hedges of forecasted sales that are denominated in foreign currencies and as hedges of foreign currency denominated financial assets or liabilities. These contracts are entered into to help protect against the risk that the eventual dollar-net-cash inflows resulting from such sales or firm commitments will be adversely affected by changes in exchange rates. We also use foreign currency forward contracts as hedges of forecasted expenses that are denominated in foreign currencies. These contracts are entered into to help protect against the risk that the eventual dollar-net-cash outflows resulting from foreign currency operating and cost of sales expenses will be adversely affected by changes in exchange rates. We designate foreign currency forward contracts as cash flow hedges of forecasted net sales or forecasted expenses. In addition, we hedge our foreign currency denominated balance sheet exposures using foreign currency forward contracts that are not designated as hedging instruments. None of our derivative instruments contain a credit-risk-related contingent feature. Cash flow hedges To help protect against the reduction in value caused by a fluctuation in foreign currency exchange rates of forecasted foreign currency cash flows resulting from international sales over the next one For derivative instruments that are designated and qualify as a cash flow hedge, the gain or loss on the derivative is reported as a component of accumulated other comprehensive income ("OCI") and reclassified into earnings in the same line item (net sales, operating expenses, or cost of sales) associated with the forecasted transaction and in the same period or periods during which the hedged transaction affects earnings. Hedge effectiveness of foreign currency forwards designated as cash flow hedges is measured by comparing the hedging instrument’s cumulative change in fair value from inception to maturity to the forecasted transaction’s terminal value. We held forward contracts designated as cash flow hedges with the following notional amounts: (In thousands) US Dollar Equivalent As of September 30, 2022 As of December 31, (Unaudited) 2021 British pound $ 19,480 $ 25,947 Chinese yuan 57,385 99,066 Euro 95,533 145,351 Hungarian forint 29,135 54,939 Japanese yen 21,507 43,128 Korean won 6,316 21,180 Malaysian ringgit 12,717 29,624 Total forward contracts notional amount $ 242,073 $ 419,235 The contracts in the foregoing table had contractual maturities of 15 months or less at September 30, 2022 and 24 months or less at December 31, 2021. At September 30, 2022, we expect to reclassify $25.1 million of gains on derivative instruments from accumulated OCI to net sales during the next twelve months when the hedged international sales occur, $5.4 million of losses on derivative instruments from accumulated OCI to cost of sales during the next twelve months when the hedged cost of sales are incurred and $4.0 million of losses on derivative instruments from accumulated OCI to operating expenses during the next twelve months when the hedged operating expenses occur. Expected amounts are based on derivative valuations at September 30, 2022. Actual results may vary materially as a result of changes in the corresponding exchange rates subsequent to this date. Other Derivatives Other derivatives not designated as hedging instruments consist primarily of foreign currency forward contracts that we use to hedge our foreign denominated monetary assets and liabilities to help protect against the change in value caused by a fluctuation in foreign currency exchange rates. We typically attempt to hedge up to 90% of our outstanding foreign denominated net receivables or net payables and typically limit the duration of these foreign currency forward contracts to approximately 90 days or less. The gain or loss on the derivatives as well as the offsetting gain or loss on the hedge item attributable to the hedged risk is recognized in current earnings under the line item “Other expense.” As of September 30, 2022 and December 31, 2021, we held foreign currency forward contracts that were not designated as hedging instruments with a notional amount of $124 million and $94 million, respectively. The following tables present the fair value of derivative instruments on our Consolidated Balance Sheets at September 30, 2022 and December 31, 2021, respectively. Asset Derivatives September 30, 2022 December 31, 2021 (In thousands) (Unaudited) Balance Sheet Location Fair Value Fair Value Derivatives designated as hedging instruments Foreign exchange contracts - ST forwards Prepaid expenses and other current assets $ 25,122 $ 8,993 Foreign exchange contracts - LT forwards Other long-term assets 241 2,908 Total derivatives designated as hedging instruments $ 25,363 $ 11,901 Derivatives not designated as hedging instruments Foreign exchange contracts - ST forwards Prepaid expenses and other current assets $ 4,912 $ 506 Total derivatives not designated as hedging instruments $ 4,912 $ 506 Total derivatives $ 30,275 $ 12,407 Liability Derivatives September 30, 2022 December 31, 2021 (In thousands) (Unaudited) Balance Sheet Location Fair Value Fair Value Derivatives designated as hedging instruments Foreign exchange contracts - ST forwards Other current liabilities $ (9,414) $ (6,425) Foreign exchange contracts - LT forwards Other long-term liabilities (790) (2,377) Total derivatives designated as hedging instruments $ (10,204) $ (8,802) Derivatives not designated as hedging instruments Foreign exchange contracts - ST forwards Other current liabilities $ (1,420) $ (666) Total derivatives not designated as hedging instruments $ (1,420) $ (666) Total derivatives $ (11,624) $ (9,468) The following tables present the effect of derivative instruments on our Consolidated Statements of Income for the three months ended September 30, 2022 and 2021, respectively: September 30, 2022 (In thousands) (Unaudited) Derivatives in Cash Flow Hedging Relationship Gain or (Loss) Recognized in OCI on Derivative Location of Gain or (Loss) Reclassified from Accumulated OCI into Income Gain or (Loss) Reclassified from Accumulated OCI into Income Foreign exchange contracts - forwards $ 5,366 Net sales $ 7,347 Foreign exchange contracts - forwards (786) Cost of sales (1,392) Foreign exchange contracts - forwards (620) Operating expenses (929) Total $ 3,960 $ 5,026 September 30, 2021 (In thousands) (Unaudited) Derivatives in Cash Flow Hedging Relationship Gain or (Loss) Recognized in OCI on Derivative Location of Gain or (Loss) Reclassified from Accumulated OCI into Income Gain or (Loss) Reclassified from Accumulated OCI into Income Foreign exchange contracts - forwards $ 7,400 Net sales $ (815) Foreign exchange contracts - forwards (1,869) Cost of sales (73) Foreign exchange contracts - forwards (1,288) Operating expenses (88) Total $ 4,243 $ (976) (In thousands) Derivatives not Designated as Hedging Instruments Location of Gain (Loss) Recognized in Income Amount of Gain (Loss) Recognized in Income Amount of Gain (Loss) Recognized in Income September 30, 2022 September 30, 2021 (Unaudited) (Unaudited) Foreign exchange contracts - forwards Other expense $ 5,622 (1,679) Total $ 5,622 $ (1,679) The following tables present the effect of derivative instruments on our Consolidated Statements of Income for the nine months ended September 30, 2022 and 2021, respectively: September 30, 2022 (In thousands) (Unaudited) Derivatives in Cash Flow Hedging Relationship Gain or (Loss) Recognized in OCI on Derivative Location of Gain or (Loss) Reclassified from Accumulated OCI into Income Gain or (Loss) Reclassified from Accumulated OCI into Income Foreign exchange contracts - forwards $ 17,502 Net sales $ 14,141 Foreign exchange contracts - forwards (3,253) Cost of sales (2,579) Foreign exchange contracts - forwards (2,262) Operating expenses (1,859) Total $ 11,987 $ 9,703 September 30, 2021 (In thousands) (Unaudited) Derivatives in Cash Flow Hedging Relationship Gain or (Loss) Recognized in OCI on Derivative Location of Gain or (Loss) Reclassified from Accumulated OCI into Income Gain or (Loss) Reclassified from Accumulated OCI into Income Foreign exchange contracts - forwards $ 23,098 Net sales $ (5,249) Foreign exchange contracts - forwards (2,675) Cost of sales (73) Foreign exchange contracts - forwards (1,818) Operating expenses (70) Total $ 18,605 $ (5,392) (In thousands) Derivatives not Designated as Hedging Instruments Location of Gain (Loss) Recognized in Income Amount of Gain (Loss) Recognized in Income Amount of Gain (Loss) Recognized in Income September 30, 2022 September 30, 2021 (Unaudited) (Unaudited) Foreign exchange contracts - forwards Other expense $ 8,409 $ (3,942) Total $ 8,409 $ (3,942)

Inventories, net

Inventories, net	9 Months Ended
	Sep. 30, 2022
Inventory Disclosure [Abstract]
Inventories, net	Inventories, net Inventories, net consist of the following: September 30, 2022 December 31, (In thousands) (Unaudited) 2021 Raw materials $ 253,698 $ 181,676 Work-in-process 14,915 14,573 Finished goods 104,931 92,994 Total $ 373,544 $ 289,243

Intangible assets, net and good

Intangible assets, net and goodwill	9 Months Ended
	Sep. 30, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
Intangible assets, net and goodwill	Intangible assets, net and goodwill Intangible assets at September 30, 2022 and December 31, 2021 are as follows: September 30, 2022 (In thousands) (Unaudited) December 31, 2021 Gross Carrying Amount Accumulated Amortization Net Carrying Amount Gross Carrying Amount Accumulated Amortization Net Carrying Amount Capitalized software development costs $ 20,964 $ (16,722) $ 4,242 $ 45,671 $ (36,457) $ 9,214 Acquired technology 171,754 (48,108) 123,646 148,155 (34,264) 113,891 Customer relationships 99,780 (28,985) 70,795 93,931 (19,717) 74,214 Patents 37,070 (30,882) 6,188 36,217 (29,316) 6,901 Other 35,539 (20,680) 14,859 32,962 (16,764) 16,198 Total $ 365,107 $ (145,377) $ 219,730 $ 356,936 $ (136,518) $ 220,418 Amortization of capitalized software development costs is computed on an individual product basis for those products available for market and is recognized based on the product’s estimated economic life, which generally range from three five ten Goodwill The carrying amount of goodwill as of September 30, 2022 was as follows: (In thousands) Amount Balance as of December 31, 2021 $ 575,992 Acquisitions 32,693 Measurement period adjustments 4,243 Foreign currency translation impact (19,780) Balance as of September 30, 2022 (unaudited) $ 593,148 Refer to Note 16 - Acquisitions of Notes to Consolidated Financial Statements for additional details on the acquisition-related amounts recorded to goodwill during the nine months ended September 30, 2022.

Leases

Leases	9 Months Ended
	Sep. 30, 2022
Leases [Abstract]
Leases	Leases We have operating leases for corporate offices, automobiles, and certain equipment. Our leases have remaining terms of 1 year to 92 years, some of which may include options to extend the leases for up to 9 years, and some of which may include options to terminate the leases within 1 year. Leases with an initial term of 12 months or less are not recorded on the balance sheet. We recognize lease expense for these leases on a straight-line basis over the lease term. Amounts related to finance lease activities and income from leasing activities were not material for the periods presented. The components of operating lease expense were as follows (unaudited): Three Months Ended Nine Months Ended (In thousands) September 30, 2022 September 30, 2021 September 30, 2022 September 30, 2021 Operating Lease Cost (1) $ 5,657 $ 5,174 $ 16,561 $ 15,712 (1) Includes variable and short-term lease costs Maturities of lease liabilities as of September 30, 2022 were as follows (unaudited): (In thousands) Years ending December 31, Operating Leases 2022 (Excluding the nine months ended September 30, 2022) $ 4,601 2023 14,472 2024 11,615 2025 8,164 2026 7,154 Thereafter 2,922 Total future minimum lease payments 48,928 Less imputed interest (3,613) Total lease liabilities $ 45,315 As of September 30, 2022, we have additional operating leases that have not commenced during the nine months ended September 30, 2022, which were not material.

Income taxes

Income taxes	9 Months Ended
	Sep. 30, 2022
Income Tax Disclosure [Abstract]
Income taxes	Income taxes We account for income taxes under the asset and liability method. Deferred tax assets and liabilities are recognized for the expected tax consequences of temporary differences between the tax bases of assets and liabilities and their reported amounts. Valuation allowances are established when necessary to reduce deferred tax assets to amounts which are more likely than not to be realized. We had a valuation allowance of $84 million at September 30, 2022 and December 31, 2021. A majority of the valuation allowance is related to the deferred tax assets of National Instruments Hungary Kft. We account for uncertainty in income taxes recognized in our financial statements using prescribed recognition thresholds and measurement attributes for financial statement disclosure of tax positions taken or expected to be taken on our tax returns. We had $11.9 million and $9.4 million of gross unrecognized tax benefits at September 30, 2022 and December 31, 2021, respectively, all of which would affect our effective income tax rate if recognized. We recorded a gross increase in unrecognized tax benefits of $1.2 million for the three months ended September 30, 2022, as a result of the tax positions taken during the current period. As of September 30, 2022, it is reasonably possible that we will recognize gross tax benefits in the amount of $1.5 million in the next twelve months due to the closing of open tax years. The nature of the uncertainty is related to tax positions taken on returns that have not been examined by the applicable tax authority. Our continuing policy is to recognize interest and penalties related to income tax matters in income tax expense. During the three months ended September 30, 2022, we recognized interest expense related to uncertain tax positions of approximately $40,000. As of September 30, 2022, we had approximately $0.4 million accrued for interest related to uncertain tax positions. The tax years 2015 through 2022 remain open to examination by the major taxing jurisdictions to which we are subject. Our provision for income taxes reflected an effective tax rate of 18% and 16% for the three months ended September 30, 2022 and 2021, respectively, and 19% and 16% for the nine months ended September 30, 2022 and 2021, respectively. For the three months ended September 30, 2022, our effective tax rate was lower than the U.S. federal statutory rate of 21% primarily as a result of deduction for foreign-derived intangible income, enhanced deduction for certain research and development expenses, and U.S. research and development tax credit, offset by, foreign taxes greater than the statutory rate, change in unrecognized tax benefits, state income taxes net of federal benefit, and nondeductible officer compensation. For the nine months ended September 30, 2022, our effective tax rate was lower than the U.S. federal statutory rate of 21% primarily as a result of deduction for foreign-derived intangible income, enhanced deduction for certain research and development expenses, and U.S. research and development tax credit, offset by foreign taxes greater than the statutory rate, excess tax expense from share-based compensation, change in unrecognized tax benefits, state income taxes net of federal benefit, and nondeductible officer compensation. For the three months ended September 30, 2021, our effective tax rate was lower than the U.S. federal statutory rate of 21% primarily as a result of an enhanced deduction for certain research and development expenses, foreign taxes lower than the statutory rate, the research and development tax credit, and the deduction for foreign-derived intangible income, offset by the U.S. tax on global intangible low-taxed income, excess tax expense from share-based compensation, nondeductible officer compensation, and state income taxes net of federal benefit. For the nine months ended September 30, 2021, our effective tax rate was lower than the U.S. federal statutory rate of 21% primarily as a result of an enhanced deduction for certain research and development expenses, the research and development tax credit and the deduction for foreign-derived intangible income, offset by the U.S. tax on global intangible low-taxed income, nondeductible officer compensation, and state income taxes net of federal benefit. Our earnings from our operations in Hungary are subject to a statutory tax rate of 9%. In addition, our research and development activities in Hungary benefit from a tax law in Hungary that provides for an enhanced deduction for qualified research and development expenses. The tax position of our Hungarian operations resulted in income tax benefits of $3.0 million and $5.9 million for the three and nine months ended September 30, 2022, respectively, and income tax benefit of $1.9 million and $2.2 million for the three and nine months ended September 30, 2021, respectively. Earnings from our operations in Malaysia are free of tax under a tax holiday effective January 1, 2013. This tax holiday expires in 2037. If we fail to satisfy the conditions of the tax holiday, this tax benefit may be terminated early. The income tax benefits of the tax holiday for the three and nine months ended September 30, 2022 were approximately $0.5 million and $1.6 million, respectively. The income tax benefits of the tax holiday for the three and nine months ended September 30, 2021 were approximately $0.6 million and $0.9 million, respectively. The impact of the tax holiday on a per share basis for each of the three and nine months ended September 30, 2022 and September 30, 2021 was approximately $0.01 per share. No other taxing jurisdictions had a significant impact on our effective tax rate. We have not entered into any advanced pricing or other agreements with the Internal Revenue Service ("IRS") with regard to any foreign jurisdictions.

Comprehensive income

Comprehensive income	9 Months Ended
	Sep. 30, 2022
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]
Comprehensive income	Comprehensive income Our OCI is comprised of net income, foreign currency translation adjustments, and unrealized gains and losses on forward contracts and securities classified as available-for-sale. The accumulated OCI, net of tax, for the nine months ended September 30, 2022 and 2021, consisted of the following: September 30, 2022 (Unaudited) (In thousands) Currency translation adjustment Investments Derivative instruments Accumulated other comprehensive income/(loss) Balance as of December 31, 2021 $ (23,179) $ — 3,048 $ (20,131) Current-period other comprehensive (loss) income (32,009) — 21,690 (10,319) Reclassified from accumulated OCI into income — — (9,703) (9,703) Income tax expense — — 2,862 2,862 Balance as of September 30, 2022 $ (55,188) $ — $ 12,173 $ (43,015) September 30, 2021 (Unaudited) (In thousands) Currency translation adjustment Investments Derivative instruments Accumulated other comprehensive income/(loss) Balance as of December 31, 2020 $ (10,066) $ (426) (10,334) $ (20,826) Current-period other comprehensive (loss) income (10,585) (162) 13,213 2,466 Reclassified from accumulated OCI into income — — 5,392 5,392 Income tax (expense) benefit — (4) 4,212 4,208 Balance as of September 30, 2021 $ (20,651) $ (584) $ 4,059 $ (17,176)

Authorized shares of common and

Authorized shares of common and preferred stock and stock-based compensation plans	9 Months Ended
	Sep. 30, 2022
Share-Based Payment Arrangement [Abstract]
Authorized shares of common and preferred stock and stock-based compensation plans	Authorized shares of common and preferred stock and stock-based compensation plans Authorized shares of common and preferred stock The total number of shares which we are authorized to issue is 365,000,000 shares, consisting of (i) 5,000,000 shares of preferred stock, par value $0.01 per share, and (ii) 360,000,000 shares of common stock, par value $0.01 per share. Stock-Based Compensation Plan Our stockholders approved our 2010 Incentive Plan (the “2010 Plan”) on May 11, 2010. At the time of approval, 3,000,000 shares of our common stock were reserved for issuance under the 2010 Plan, as well as the 3,362,304 shares of common stock that were reserved but not issued under the 1994 Plan and the 2005 Incentive Plan (the "2005 Plan") as of May 11, 2010, and any shares that are returned to the 1994 Plan and the 2005 Plan as a result of the forfeiture or termination of options or RSUs or repurchase of shares issued under those plans. The 2010 Plan provided for the granting of incentive awards in the form of restricted stock and RSUs to employees, directors and consultants of the Company and employees and consultants of any parent or subsidiary of the Company. Awards vest over a three five Our stockholders approved our 2015 Equity Incentive Plan (the “2015 Plan”) on May 12, 2015. At the time of approval, 3,000,000 shares of our common stock were reserved for issuance under the 2015 Plan, as well as the 2,518,416 shares of common stock that were reserved but not issued under the 2010 Plan as of May 12, 2015, and any shares that were returned to the 1994 Plan, 2005 Plan, and the 2010 Plan as a result of the forfeiture or termination of options or RSUs or repurchase of shares issued under those plans. The 2015 Plan provides for the granting of incentive awards in the form of restricted stock and RSUs to employees, directors and consultants of the Company and employees and consultants of any parent or subsidiary of the Company and such awards may be subject to performance-based vesting conditions. Awards generally vest over a three four five five Our stockholders approved our 2020 Equity Incentive Plan (the “2020 Plan”) on May 5, 2020. At the time of approval, 4,500,000 shares of our common stock were reserved for issuance under the 2020 Plan, as well as the 567,142 shares of common stock that were reserved but not issued under the 2015 Plan as of May 5, 2020, and any shares that were returned to the 2005 Plan, 2010 Plan, and 2015 Plan as a result of the forfeiture or termination of options or RSUs or repurchase of shares issued under those plans. The 2020 Plan provides for the granting of incentive awards in the form of restricted stock and RSUs to employees, directors and consultants of the Company and employees and consultants of any parent or subsidiary of the Company. Awards generally vest over a one two three Our stockholders approved our 2022 Equity Incentive Plan (the “2022 Plan”) on May 10, 2022. At the time of approval, 4,500,000 shares of our common stock were reserved for issuance under the 2022 Plan, as well as the 1,568,571 shares of common stock that were reserved but not issued under the 2020 Plan as of May 10, 2022, and any shares that were returned to the 2005 Plan, 2010 Plan, 2015 Plan and 2020 Plan as a result of the forfeiture, repurchase or termination of unissued shares subject to options or RSUs issued under those plans. The 2022 Plan provides for the granting of incentive awards in the form of restricted stock and RSUs to employees, directors and consultants of the Company and employees and consultants of any parent or subsidiary of the Company. Awards generally vest over a one two three Performance-based stock units During the nine months ended September 30, 2022 and 2021, we granted 164,843 and 130,006 performance-based restricted stock units (“PRSUs”), respectively, to executive officers pursuant to the 2020 Plan. The PRSUs may be earned based on our total shareholder return (“TSR”) compared to the TSR of the Russell 2000 Index (the “Index”) over a three-year performance period. For the PRSUs granted during the nine months ended September 30, 2022, the three-year performance period commenced on January 1, 2022 and will end on December 31, 2024, and for the PRSUs granted during the nine months ended September 30, 2021, the three year performance commenced on January 1, 2021 and will end on December 31, 2023, using the average daily closing price over a 30-day lookback in each case. The number of awards earned could range from zero to two times the target number of shares granted. The fair values of PRSUs are estimated using a Monte Carlo simulation. The determination of fair value of the PRSUs is based on our stock price and a number of assumptions including the expected volatility, expected dividend yield and the risk-free interest rate. The expected volatility at the date of grant was based on the historical volatilities of our stock and the companies included in the Index over the performance period. The Monte Carlo model is based on random projections of stock-price paths and must be repeated numerous times to achieve a probabilistic assessment. The key assumptions used in valuing these market-based awards are as follows: Nine Months Ended (unaudited) September 30, 2022 September 30, 2021 Number of simulations 100,000 100,000 Expected volatility 37.81% 40.60% Expected life in years 2.95 years 2.95 years Risk-free interest rate 1.33% 0.21% Dividend yield 2.52% 2.66% The weighted average grant date fair value of the market-based awards, as determined by the Monte Carlo valuation model, was $59.65 per share and $66.97 per share in 2022 and 2021, respectively. Employee stock purchase plan Our employee stock purchase plan (“ESPP”) permits substantially all domestic employees and employees of designated subsidiaries to acquire our common stock at a purchase price of 85% of the lower of the market price at the beginning or the end of the purchase period. The plan has quarterly purchase periods beginning on February 1, May 1, August 1 and November 1 of each year. Employees may designate up to 15% of their compensation for the purchase of common stock under the ESPP. On May 10, 2022, our stockholders approved an additional 3,000,000 shares for issuance under our ESPP. At September 30, 2022, we had 4,270,314 shares of common stock reserved for future issuance under the ESPP. We issued 791,207 shares under this plan in the nine months ended September 30, 2022 and the weighted average purchase price was $32.16 per share. During the nine months ended September 30, 2022, we did not make any changes in accounting principles or methods of estimates with respect to our ESPP. Stock repurchases and retirements On April 21, 2010, our Board of Directors authorized a program to repurchase shares of our common stock from time to time, depending on market conditions and other factors (the “2019 Program”). The Board has amended the 2019 Program several times over the years to increase the number of shares that may be purchased under the program. On October 23, 2019, our Board amended the 2019 Program to increase the number of shares that may be repurchased by 3,000,000 shares. On January 19, 2022, our Board of Directors approved a new stock repurchase plan for up to $250 million of our common stock, effective immediately (the "2022 Program"). This new repurchase program is in addition to the existing 2019 Program. Under the 2022 Program, shares may be repurchased from time to time in open market transactions, in privately negotiated transactions or otherwise. The timing and the other terms of the repurchase will depend on a variety of factors, including legal requirements, economic and market conditions, and other investment opportunities. The 2022 Program may be changed, suspended or discontinued at any time and does not have a specified expiration date. As of March 31, 2022, there were no shares remaining available for repurchase under the 2019 Program. As of September 30, 2022, there was $109 million available for repurchase under the 2022 Program. During the three months ended September 30, 2022, we repurchased 2,033,135 shares of our common stock at a weighted average price per share of $40.25 under the 2022 Program. During the nine months ended September 30, 2022, we repurchased 3,792,063 shares of our common stock at a weighted average price of $40.04 under the 2019 Program and 2022 Program. During the three and nine months ended September 30, 2021, we repurchased 599,066 shares of our common stock at a weighted average price per share of $41.73. under the 2019 Program.

Segment and geographic informat

Segment and geographic information	9 Months Ended
	Sep. 30, 2022
Segment Reporting [Abstract]
Segment and geographic information	Segment and geographic information We operate as one operating segment. Operating segments are defined as components of an enterprise for which separate financial information is evaluated regularly by the chief operating decision maker, who is our chief executive officer, in deciding how to allocate resources and in assessing performance. Our chief operating decision maker evaluates our financial information and resources and assesses the performance of these resources on a consolidated basis. Since we operate as one operating segment, all required financial segment information can be found in the condensed consolidated financial statements and the notes thereto. We sell our products in three geographic regions which consist of the Americas region, Europe, Middle East and Africa region ("EMEA"), and Asia-Pacific region ("APAC"). Our sales to these regions share similar economic characteristics including the nature of products and services we sell, the type and class of customers, and the methods used to distribute our products and services. Revenue from the sale of our products, which are similar in nature, and software maintenance are reflected as total net sales in our Consolidated Statements of Income. (See Note 2 - Revenue of Notes to Consolidated Financial Statements for total net sales by the geographic regions in which we operate). The following table presents summarized information for net sales by country. Revenues from external customers are generally attributed to countries based upon the customer's location. Net sales attributable to each individual foreign country outside the U.S. and China were not material. (in millions) United States China (1) Rest of the World Total Net sales: Three months ended September 30, 2022 $ 185 $ 57 $ 186 $ 428 Three months ended September 30, 2021 $ 141 $ 59 $ 167 $ 367 Nine months ended September 30, 2022 $ 489 $ 178 $ 542 $ 1,209 Nine months ended September 30, 2021 $ 388 $ 172 $ 489 $ 1,049 (1): Includes Mainland China and the Hong Kong Special Administrative Region The following table presents summarized information for long-lived assets by country. Long-lived assets attributable to each individual country outside the U.S., Hungary and Malaysia were not material. Long-lived assets consist of property, plant, and equipment and operating lease right-of-use assets excluding intangible assets. (in millions) United States Hungary Malaysia Rest of the World Total Long-lived Assets: September 30, 2022 $ 123 $ 52 $ 82 $ 57 $ 314 December 31, 2021 $ 125 $ 51 $ 76 $ 60 $ 312

Debt

Debt	9 Months Ended
	Sep. 30, 2022
Debt Disclosure [Abstract]
Debt	Debt The following table presents the amounts outstanding related to our borrowing arrangements discussed above as of September 30, 2022 (unaudited) and December 31, 2021, respectively: September 30, December 31, (in thousands) 2022 2021 Secured Credit Agreement 2022 Term loan (effective interest rate of 4.7%) $ 500,000 $ — 2021 Revolving credit facility (effective interest rate of 4.7%) 70,000 300,000 Total Debt 570,000 300,000 Less: Unamortized debt issuance costs (2,232) — Less: Current portion of total debt (25,000) — Total Debt, non-current $ 542,768 $ 300,000 Debt Issuance Costs As of September 30, 2022, debt issuance costs of approximately $2.2 million attributable to the revolving credit facility are presented within "Other long-term assets" in our Consolidated Balance Sheet and debt issuance costs of approximately $2.2 million attributable to the term loan are presented within "Debt, non-current". These amounts are amortized to interest expense over the life of the Credit Agreement. Credit Agreement On August 24, 2022, we entered into a Third Amended and Restated Credit Agreement (the "Credit Agreement") with Wells Fargo Bank, National Association, as the administrative agent, swingline lender and issuing lender (the "Administrative Agent"), Wells Fargo Securities, LLC, BofA Securities, Inc. and Citibank, N.A., as joint lead arrangers and joint bookrunners, BofA Securities, Inc. and Citibank, N.A., as syndication agents, and the lenders party thereto. The Credit Agreement amends and restates and refinances our Second Amended and Restated Credit Agreement, dated as of June 18, 2021, by and among us, the lenders from time-to-time party thereto and Wells Fargo Bank, National Association, as the administrative agent. All outstanding loans under the Prior Credit Agreement were repaid in full in connection with the entry into the Credit Agreement. The replacement of the previous debt facility with the Credit Agreement was treated as a debt modification and the remaining balance of unamortized debt issuance costs were allocated to the new loan facilities, as described below. The Credit Agreement provides for an initial $1 billion credit facility consisting of (a) a secured revolving loan facility in an aggregate principal amount of up to $500 million at any time outstanding, with a sublimit of $25 million for the issuance of letters of credit, and (b) a secured term loan facility in an aggregate principal amount of $500 million. Subject to the terms of the Credit Agreement, including obtaining commitments from existing lenders or new lenders, we may request additional term loan s and/or revolving loan commitments. The revolving loan facility and the term loan facility terminate, and all revolving loans outstanding and/or outstanding term loan amounts (together with accrued interest and fees) are payable in full, on August 24, 2027, unless terminated earlier pursuant to the terms of the Credit Agreement. The term loans amortize in quarterly payments equal to 1.25% of the original principal amount of the term loans, with the remaining outstanding balance due at maturity. The term loans and revolving loans accrue interest, at our option, at (i) a base rate equal to the highest of (a) the prime rate, (b) the federal funds rate plus 0.50%, and (c) an adjusted term SOFR for an interest period of one month plus 1.00%, in each case, plus a margin of 0.25% to 0.75%, or (ii) an adjusted term SOFR (for an interest period of one, three or six months) plus a margin of 1.25% to 1.75%, with the margin being determined based upon our consolidated total net leverage ratio. The Credit Agreement contains financial covenants requiring us to maintain a maximum consolidated total net leverage ratio of less than or equal to 3.50 to 1.00, which increases to 4.00 to 1.00 for a specified period following material acquisitions, and a minimum consolidated interest coverage ratio of greater than or equal to 3.00 to 1.00, in each case determined in accordance with the Credit Agreement. The Credit Agreement provides for a commitment fee of 0.150% to 0.250% per annum, determined based upon our consolidated total net leverage ratio, on the average daily unused portion of the revolving committed amount, payable quarterly in arrears. Under the circumstances described in the Credit Agreement, certain of our wholly owned domestic subsidiaries (the "Subsidiary Guarantors") are required to enter into a guaranty agreement ("Guaranty") in favor of the Administrative Agent guarantying our obligations under the Credit Agreement, among other things. As of September 30, 2022, there were no Subsidiary Guarantors, and no Guaranty had been executed. In connection with the Credit Agreement, we entered into a Second Amended and Restated Collateral Agreement (the "Collateral Agreement") pursuant to which we granted a continuing security interest on substantially all of our assets, in favor of the Administrative Agent (for the benefit of the lenders under the Credit Agreement), to secure our obligations under the Credit Agreement. Subsidiary Guarantors are required to join the Collateral Agreement and make similar grants of security interests. The Credit Agreement contains customary affirmative and negative covenants. The affirmative covenants include, among other things, delivery of financial statements, compliance certificates and notices, payment of taxes and other obligations, maintenance of existence, maintenance of properties and insurance, maintenance of books and records, and compliance with applicable laws and regulations. The negative covenants include, among other things, limitations on indebtedness, liens, mergers, consolidations, acquisitions and sales of assets, investments, changes in the nature of the business, affiliate transactions and certain restricted payments. The Credit Agreement contains customary events of default including, among other things, payment defaults, breaches of covenants or representations and warranties, cross-defaults with certain other indebtedness, bankruptcy and insolvency events, judgment defaults and change in control events, subject to grace periods in certain instances. Upon an event of default, the Administrative Agent and the lenders may declare all or a portion of the outstanding obligations payable by us to be immediately due and payable and exercise other rights and remedies provided for under the Credit Agreement. Under certain circumstances, a default interest rate will apply on all obligations during the existence of an event of default under the Credit Agreement at a per annum interest rate equal to 2.00% above the otherwise applicable interest rate. Proceeds of revolving loans of the Credit Agreement may be used for working capital and other general corporate purposes including acquisitions, share repurchases and dividend payouts. We may prepay the loans under the Credit Agreement in whole or in part at any time without premium or penalty.

Commitments and contingencies

Commitments and contingencies	9 Months Ended
	Sep. 30, 2022
Commitments and Contingencies Disclosure [Abstract]
Commitments and contingencies	Commitments and contingencies We provide product warranties with varying lengths of time and terms. Products sold with one-year limited warranties do not cover anything beyond ensuring that the product functions as intended and are accounted for as assurance-type warranties. Products bundled with multi-year warranty and services obligations or separately-priced optional warranty programs are accounted for as separate performance obligations. For the assurance-type warranties described above, a provision is made for estimated future warranty costs at the time of the sale for the estimated costs that may be incurred under the limited warranty. Our estimate is based on historical experience and product sales during the period. The warranty reserve for the nine months ended September 30, 2022 and 2021 was as follows: Nine Months Ended September 30, (In thousands) (Unaudited) 2022 2021 Balance at the beginning of the period $ 3,210 $ 2,872 Accruals for warranties issued during the period 1,362 2,037 Accruals related to pre-existing warranties (567) (636) Settlements made (in cash or in kind) during the period (1,676) (1,291) Balance at the end of the period $ 2,329 $ 2,982 In the ordinary course of business, we enter into purchase orders with suppliers for the purchase of goods and services, including non-cancelable agreements for certain inventory components ("unconditional purchase obligations"). The majority of our unconditional purchase obligations relate to amounts due within the next 12 months. As of September 30, 2022, our unconditional purchase obligations primarily consist of payments to various suppliers for customized inventory and inventory components. As of September 30, 2022, our future payments under noncancellable unconditional purchase obligations with a remaining term in excess of one year were approximately $20.9 million. As of December 31, 2021, our future payments under noncancellable unconditional purchase obligations with a remaining term in excess of one year were approximately $11.7 million. As of September 30, 2022, our outstanding guarantees for payment of customs and foreign grants were not material.

Restructuring

Restructuring	9 Months Ended
	Sep. 30, 2022
Restructuring and Related Activities [Abstract]
Restructuring	Restructuring On October 26, 2021, we initiated a restructuring plan (the “2021 Plan”) that resulted in the site closure of our facilities in Aachen, Germany. This targeted restructuring effort was intended to further optimize our research and development operations and accelerate investment in strategic growth opportunities. The majority of these charges were recognized during the fourth quarter of 2021. During the third quarter of 2022, we also incurred restructuring-related expenses of less than $1.0 million related to a targeted headcount reduction that will be substantially complete by December 31, 2022. These severance-related charges are presented within "General and Administrative" below. On October 29, 2020, we announced a workforce reduction plan (the “2020 Plan”) intended to accelerate our growth strategy and further optimize our operations and cost structure. The majority of charges related to this Plan were recognized during the three months ended December 31, 2020. We implemented a majority of the actions under this Plan as of December 31, 2021. During the third quarter of 2022, we recorded an inventory write-down of approximately $3.9 million, presented in "Cost of sales", related to the final transition of manufacturing activities from our RF and microwave test business from Santa Clara, California to our manufacturing hubs in Hungary and Malaysia. The majority of the other charges incurred are related to severance payments. A summary of the charges in our consolidated statement of operations resulting from our restructuring activities is shown below: Three Months Ended September 30, Nine Months Ended September 30, (In thousands) (Unaudited) (Unaudited) 2022 2021 2022 2021 Cost of sales $ 3,944 $ (7) $ 3,944 $ (50) Research and development 37 65 729 444 Sales and marketing — (223) — 3,924 General and administrative 813 54 813 2,159 Total restructuring and other related costs $ 4,794 $ (111) $ 5,486 $ 6,477 A summary of balance sheet activity during 2022 related to our restructuring activity is shown below: (in thousands) Restructuring Liability Balance as of December 31, 2021 $ 11,520 Income statement expense 1,542 Cash payments (10,034) Balance as of September 30, 2022 $ 3,028 The restructuring liability of $3.0 million at September 30, 2022 related primarily to severance payments associated with the restructuring activity is recorded in the “accrued compensation” line item of our consolidated balance sheet.

Acquisitions

Acquisitions	9 Months Ended
	Sep. 30, 2022
Business Combination and Asset Acquisition [Abstract]
Acquisitions	Acquisitions Acquisition of Test Systems Business (“TS Business”) From Kratzer Automation AG (“Kratzer”) On May 2, 2022, we completed the acquisition of certain assets of, and assumed certain liabilities of, the test systems business of Germany-based Kratzer. As part of this integrated transaction, we also purchased 100% of the shares in certain subsidiaries of Kratzer including Kratzer Automation S.a.r.l. ("Kratzer France"), Kratzer Automation Inc. ("Kratzer US") and Kratzer Automation (Shanghai) Co., Ltd. ("Kratzer China"). The acquisitions of Kratzer France, Kratzer US, and Kratzer China were completed on June 1, 2022, June 2, 2022, and August 26, 2022, respectively. This transaction was accounted for as a business combination using the acquisition method of accounting. Total cash consideration for the transaction was $56.8 million inclusive of $0.7 million in cash acquired. All of the acquired assets and liabilities of the TS Business have been recorded at their respective fair values as of the acquisition date. The acquisition was funded by cash on hand. Transaction costs have been expensed as incurred. We expensed $2.2 million of transaction costs related to the acquisition of the TS Business, which are included in selling, general and administrative expenses. The excess of the purchase price over the net assets acquired was recorded as goodwill. The goodwill generated from the acquisition is primarily attributed to expected growth in the scope of and market opportunities for our existing offerings related to vehicle electrification test systems and other related applications. The goodwill is deductible locally and the U.S. over 15 years for federal income tax purposes. Fair value of net assets acquired and liabilities assumed The information below represents the preliminary purchase price allocation of the TS Business (in thousands): May 2, 2022 Consideration Transferred $ 56,806 Cash and cash equivalents 672 Accounts receivable 3,756 Inventories 5,209 Prepaid expenses and other current assets 1,936 Property and equipment 1,151 Goodwill 19,181 Intangible assets 35,502 Operating lease right-of-use assets 4,642 Other long-term assets 109 Accounts payable and accrued expenses (999) Accrued compensation (464) Operating lease liabilities - current (1,051) Other current liabilities (9,431) Other taxes payable 95 Operating lease liabilities - non-current (3,502) Net Assets Acquired $ 56,806 The preliminary purchase price allocation related to the acquisition was not finalized as of September 30, 2022. These preliminary estimates of the fair value of the assets acquired and the liabilities assumed are based on the information currently available, and we are continuing to evaluate the underlying inputs and assumptions used in our valuations. Accordingly, these preliminary estimates are subject to change during the measurement period, which is up to one year from the date of acquisition. A decrease in the fair value of assets acquired or an increase in the fair value of liabilities assumed in the acquisition would result in a corresponding increase in the amount of goodwill acquired. The primary areas of purchase price that are not yet finalized relate to intangible assets, income taxes and residual goodwill. Acquired intangible assets will be amortized over their estimated useful lives on a straight-line basis. The following table summarizes the preliminary purchase price allocation and the preliminary average remaining useful lives for identifiable intangible assets acquired. Estimated Fair Value (in thousands) Estimated Useful Lives (in years) Customer relationships $ 5,030 8 Developed software 27,720 5 Trade name contractual rights 2,570 2 Other 182 4-12 Total 35,502 Customer relationships represent the fair value of future projected revenue that will be derived from sales of products to existing customers. The economic useful life was determined by examining the period of time over which a target cumulative present value of discounted cash flows could be achieved. Developed software represents the fair value of automation systems for performing test bench tasks and management systems for all resources and accruing data in the test field. The economic life of this software is estimated to be 5-8 years based on the expected future utilization of the software in its current form. Results of operations of the business acquired have been included in our condensed consolidated financial statements subsequent to the dates of acquisition. Pro-forma results of operations have not been presented as the impact of the acquired operations was not material. Acquisition of Electronic Vehicle (“EV”) Business From Heinzinger Electronic GmbH ("Heinzinger") On February 28, 2022, we completed the acquisition of the systems business of Heinzinger for $22.5 million in total cash consideration, subject to certain post-closing adjustments. This transaction is being accounted for as a business combination using the acquisition method of accounting. All of the acquired assets and liabilities of Heinzinger have been recorded at their respective fair values as of the acquisition date. We recognized approximately $14 million of goodwill and $7 million of other intangible assets as part of our preliminary purchase price allocation. Transaction costs have been expensed as incurred and were not material to the periods presented. The acquisition was funded by cash on hand. The preliminary purchase price allocation related to the acquisition was not finalized as of September 30, 2022, and is based upon a preliminary valuation which is subject to change as we obtain additional information with respect to certain intangible assets and income taxes. Pro-forma results of operations have not been presented as the impact of the acquired operations was not material. The excess of the purchase price over the net assets acquired was recorded as goodwill. Goodwill generated from the acquisition is primarily attributable to expected growth in the scope of and market opportunities for our existing offerings related to vehicle electrification and other related applications. Goodwill is deductible for tax purposes. Acquisition of N H Research, LLC ("NHR") On October 19, 2021, we completed the acquisition of NHR, a manufacturer of test and measurement solutions for high power applications including EV and batteries. As a result of acquiring 100% of the outstanding share capital of NHR, NHR became our wholly owned subsidiary. This transaction is being accounted for as a business combination using the acquisition method of accounting. All of the acquired assets and liabilities of NHR have been recorded at their respective fair values as of the acquisition date. Transaction costs have been expensed as incurred. At the acquisition date, total consideration transferred was approximately $205 million, inclusive of $3 million in cash acquired. The excess of the purchase price over the net assets acquired was recorded as goodwill. Goodwill generated from the acquisition is primarily attributable to expected growth in the scope of and market opportunities for our existing offerings related to vehicle electrification and other related applications. As a result of the structure of the transaction, the balance of goodwill is deductible in the U.S. over 15 years for income tax purposes. The acquisition was funded primarily by cash on hand in addition to $200 million drawn under our existing credit facility in October 2021. See Note 13 – Debt of Notes to Consolidated Financial Statements for further information on our outstanding borrowings. During the year ended December 31, 2021, we expensed $6 million of transaction costs in connection with the acquisition of NHR, which were included in operating expenses. During the first quarter of 2022, we recorded a measurement period adjustment to our preliminary estimate of the fair value of liabilities assumed related to amounts owed for certain pre-acquisition activities. The increase to the fair value of acquired liabilities was $5.1 million, with a corresponding increase to goodwill. The change to this provisional amount had no impact to the current period income statement. During the second quarter of 2022, we recorded measurement period adjustments to total consideration transferred related to amounts received for certain pre-acquisition activities and certain post-closing adjustments. The net decrease to total consideration transferred was $0.8 million, with a corresponding decrease to goodwill. This change had no impact to the current period income statement. Fair value of net assets acquired and liabilities assumed The information below represents the preliminary purchase price allocation of NHR (in thousands): October 19, 2021 Consideration Transferred $ 205,396 Cash 2,935 Accounts receivable, net 3,902 Inventories, net 4,764 Property and equipment, net 287 Other assets and liabilities (4,621) Intangible assets 98,510 Goodwill 102,090 Accounts payable and accrued expenses (2,186) Deferred revenue (285) Net assets acquired $ 205,396 Our preliminary estimates of the fair value of the assets acquired and the liabilities assumed are based on the information currently available, and we are continuing to evaluate the underlying inputs and assumptions used in our valuations. Accordingly, these preliminary estimates are subject to change during the measurement period, which is up to one year from the date of acquisition. A decrease in the fair value of assets acquired or an increase in the fair value of liabilities assumed in the acquisition would result in a corresponding increase in the amount of goodwill acquired. The primary areas of the purchase price that are not yet finalized relate to certain liabilities related to preacquisition activities and residual goodwill. Acquired intangible assets will be amortized over their estimated useful lives on a straight-line basis. The following table summarizes the preliminary purchase price allocation, and the preliminary average remaining useful lives, for identifiable intangible assets acquired: Estimated Fair Value (in thousands) Estimated Useful Lives (in years) Customer relationships $ 54,350 7 Developed software 6,010 2-7 Existing product configurations 28,300 9 In-process research and development (IPR&D) 4,030 Indefinite Trade name 5,820 6 Total $ 98,510 Customer relationships represent the fair value of future projected revenue that will be derived from sales of products to existing customers. Customer relationships were valued using the multi-period excess earnings method of the income approach. This method reflects the present value of the projected cash flows that are expected to be generated by customer relationships less charges representing the contribution of other assets to those cash flows. The economic useful life was determined by examining the period of time over which a target cumulative present value of discounted cash flows could be achieved. Existing product configurations represent the existing hardware configurations of products sold by NHR. These products are created from component parts and assembled based on their intended purpose and application. Existing product configurations were valued using the avoided costs / lost profits method. The fair value represents the total costs that would be avoided by having this asset in place. The economic useful life was determined based on the number of years since launch for each product compared to the expected total life of each product. Unaudited Pro Forma Information The following unaudited pro forma financial information presents combined results of operations for the periods presented, as if the NHR acquisition had occurred on January 1, 2020, with adjustments to give effect to pro forma events that are directly attributable to the acquisition. These pro forma adjustments include additional amortization expense for the identifiable intangible assets and an increase in interest expense related to the additional borrowings entered into in connection with the acquisition, net of tax effects. For the pro forma presentation, given the assumed acquisition date of January 1, 2020, transaction and integration costs that were incurred at or subsequent to the actual acquisition date have been included in the calculation of pro forma net income for the three and nine months ended September 30, 2021, whereas transaction and integration costs that were incurred prior to the acquisition date have been excluded from the calculation of pro forma net income. The unaudited pro forma results are presented for informational purposes only and are not necessarily indicative of what actual results of operations would have been if the acquisition had occurred as the beginning of the period presented, nor are they indicative of future results of operations. The unaudited pro forma results do not include the impact of synergies, nor any potential impacts on current or future market conditions which could alter the unaudited pro forma results. Three months ended September 30, Nine Months Ended September 30, (in thousands) 2021 2021 Net sales $ 376,654 $ 1,075,653 Net income $ 27,460 $ 48,973 Other Acquisitions During the second quarter of 2021, we also completed the acquisition of a software company that specialized in signal processing and hi-fi simulation software for validation of autonomous vehicles and advanced driver assistance systems (ADAS), for approximately $20 million in total cash consideration, subject to certain post-closing adjustments. This transaction was accounted for as a business combination using the acquisition method of accounting. All of the acquired assets and liabilities of the software company have been recorded at their respective fair values as of the acquisition date. We recognized approximately $17 million of goodwill and $4 million of other intangible assets as part of our purchase price allocation. Transaction costs have been expensed as incurred and were not material to the periods presented. Pro-forma results of operations have not been presented because the effects of the acquired operations were not material.

Subsequent events

Subsequent events	9 Months Ended
	Sep. 30, 2022
Subsequent Events [Abstract]
Subsequent events	Subsequent events Dividends On October 19, 2022, our Board of Directors declared a quarterly cash dividend of $0.28 per common share, payable on November 28, 2022, to stockholders of record as of the close of business on November 7, 2022.

Basis of presentation (Policies

Basis of presentation (Policies)	9 Months Ended
	Sep. 30, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis of presentation	Basis of presentation The accompanying unaudited consolidated financial statements should be read in conjunction with the consolidated financial statements and notes thereto for the fiscal year ended December 31, 2021, included in our Annual Report on Form 10-K filed with the Securities and Exchange Commission ("SEC") on February 22, 2022 (the "Form 10-K"). In our opinion, the accompanying consolidated financial statements reflect all adjustments (consisting only of normal recurring items) considered necessary to state fairly our financial position at September 30, 2022 and December 31, 2021, the results of our operations and comprehensive income for the three and nine months ended September 30, 2022 and 2021, our cash flows for the nine months ended September 30, 2022 and 2021 and our statement of stockholders' equity for the three and nine months ended September 30, 2022 and 2021. Our operating results for the three and nine months ended September 30, 2022 are not necessarily indicative of the results that may be expected for the year ending December 31, 2022. These financial statements have been prepared in accordance with accounting principles generally accepted in the United States.
Recent Accounting Pronouncements and Summary of Significant Accounting Policies	Recent Accounting Pronouncements In October 2021, the Financial Accounting Standards Board ("FASB") issued ASU No. 2021-08—Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers. The new guidance requires contract assets and contract liabilities acquired in a business combination to be recognized in accordance with ASC Topic 606 as if the acquirer had originated the contracts. We early adopted the standard on January 1, 2022. The adoption of this accounting standard update did not have a material effect on our consolidated financial statements and related disclosures. In November 2021, the FASB issued Accounting Standards Update ("ASU") No. 2021-10- Government Assistance, to increase transparency of government assistance including the disclosure of (1) the types of assistance, (2) an entity’s accounting for the assistance, and (3) the effect of the assistance on an entity’s financial statements. ASU 2021-10 is effective for annual periods beginning after December 15, 2021. Early adoption is permitted. We are currently evaluating the impact of this accounting standard update on our annual financial statement disclosures. In September 2022, the FASB issued ASU No. 2022-04-Supplier Finance Programs (Subtopic 405-50): Disclosure of Supplier Finance Program Obligations. The amendments in Update 2022-04 require that a buyer in a supplier finance program disclose sufficient information about the program to allow a user of financial statements to understand the program’s nature, activity during the period, changes from period to period, and potential magnitude. The amendments in this Update do not affect the recognition, measurement, or financial statement presentation of obligations covered by supplier finance programs. The amendments in this Update are effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years, except for the amendment on rollforward information, which is effective for fiscal years beginning after December 15, 2023. Early adoption is permitted. We are currently evaluating the impact of this accounting standard update on our annual financial statement disclosures. Although there are several other accounting pronouncements recently issued by the FASB, we do not expect the adoption of any of these accounting pronouncements to have material impact on our consolidated financial statements. Summary of Significant Accounting Policies There were no material changes to our significant accounting policies during the three and nine months ended September 30, 2022 compared to the significant accounting policies described in our Form 10-K.
Earnings Per Share	Earnings Per ShareBasic earnings per share (“EPS”) is computed by dividing net income by the weighted average number of common shares outstanding during each period. Diluted EPS is computed by dividing net income by the weighted average number of common shares and common share equivalents outstanding (if dilutive) during each period. The number of common share equivalents, which includes restricted stock units ("RSUs"), is computed using the treasury stock method.

Basis of presentation (Tables)

Basis of presentation (Tables)	9 Months Ended
	Sep. 30, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Schedule of Other (Expense) Income, net	Other (expense) income, net consisted of the following amounts: Three Months Ended September 30, Nine Months Ended September 30, (In thousands) (Unaudited) (Unaudited) 2022 2021 2022 2021 Interest income $ 103 $ 56 $ 207 $ 330 Interest expense (4,851) (657) (8,643) (2,584) Gain (Loss) from equity-method investments 353 278 483 (5,082) Net foreign exchange loss (3,625) (1,226) (5,560) (2,681) Other gain (loss) 2,870 (271) 4,891 166 Other expense, net $ (5,150) $ (1,820) $ (8,622) $ (9,851)
Schedule of Other Current Liabilities	Other current liabilities on our consolidated balance sheet includes the following amounts (in thousands): As of September 30, 2022 As of December 31, (unaudited) 2021 Income taxes payable - current $ 17,211 $ 14,457 Hedge payable - current 10,833 7,091 Employer social security taxes - current — 5,785 Other 24,035 13,338 Total $ 52,079 $ 40,671
Schedule of Reconciliation of the Denominators used to Calculate Basic and Diluted EPS	The reconciliation of the denominators used to calculate basic EPS and diluted EPS for the three and nine months ended September 30, 2022 and 2021 are as follows (in thousands): Three Months Ended September 30, Nine Months Ended September 30, (Unaudited) (Unaudited) 2022 2021 2022 2021 Weighted average shares outstanding-basic 132,044 133,031 132,040 132,657 Plus: Common share equivalents RSUs 537 655 961 1,172 Weighted average shares outstanding-diluted 132,581 133,686 133,001 133,829

Revenue (Tables)

Revenue (Tables)	9 Months Ended
	Sep. 30, 2022
Revenue from Contract with Customer [Abstract]
Schedule of Disaggregation of Revenue	Total net sales based on the timing of transfer of goods or services to customers and geographic region are as follows: Three Months Ended September 30, (Unaudited) 2022 2021 (In thousands) Net sales: Point-in-Time (1) Over Time Total Point-in-Time (1) Over Time Total Americas $ 166,318 $ 26,643 $ 192,961 $ 125,069 $ 23,835 $ 148,904 EMEA 91,249 19,087 110,336 72,430 22,433 94,863 APAC 114,100 10,531 124,631 112,931 10,464 123,395 Total net sales (1) $ 371,667 $ 56,261 $ 427,928 $ 310,430 $ 56,732 $ 367,162 (1) Net sales contain s hedging gains and losses, which do not represent revenues recognized from customers. See Note 5 - Derivative instruments and hedging activities of Notes to Consolidated Financial Statements for more information on the impact of our hedging activities on our results of operations. Nine Months Ended September 30, (Unaudited) 2022 2021 (In thousands) Net sales: Point-in-Time (1) Over Time Total Point-in-Time (1) Over Time Total Americas $ 432,402 $ 78,946 $ 511,348 $ 341,870 $ 68,436 $ 410,306 EMEA 247,687 60,807 308,494 204,786 64,769 269,555 APAC 357,088 31,769 388,857 337,455 31,724 369,179 Total net sales (1) $ 1,037,177 $ 171,522 $ 1,208,699 $ 884,111 $ 164,929 $ 1,049,040 (1) Net sales contains hedging gains and losses, which do not represent revenues recognized from customers. The industry grouping used to disaggregate net sales is determined at the customer account level. Accounts assigned to one of our three industry-specific groupings are either designated as Semiconductor and Electronics, Transportation, or Aerospace, Defense and Government. We are able to leverage the investments in these areas to also serve a broad base of diverse customers in the other industries we serve, which are included in our Portfolio grouping. Our recent acquisitions described in Note 16 are presented within the "Transportation" industry grouping below. Three Months Ended September 30, Nine Months Ended September 30, (In thousands) (Unaudited) Industry Grouping 2022 2021 2022 2021 Semiconductor & Electronics 101,678 93,892 320,920 292,114 Transportation 83,692 52,954 212,471 149,410 Aerospace, Defense & Government 104,641 92,646 297,569 256,211 Portfolio 137,917 127,670 377,739 351,305 Total net sales $ 427,928 $ 367,162 $ 1,208,699 $ 1,049,040
Schedule of Changes in Unearned Revenue	Changes in deferred revenue, current and non-current, during the nine months ended September 30, 2022 were as follows: (In thousands) Amount Balance as of December 31, 2021 $ 170,640 Deferral of revenue billed in current period, net of recognition 130,948 Recognition of revenue deferred in prior periods (118,902) Foreign currency translation impact (14,252) Balance as of September 30, 2022 (unaudited) $ 168,434

Fair value measurements (Tables

Fair value measurements (Tables)	9 Months Ended
	Sep. 30, 2022
Fair Value Disclosures [Abstract]
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis	Assets and liabilities measured at fair value on a recurring basis are summarized below: Fair Value Measurements at Reporting Date Using (In thousands) (Unaudited) Description September 30, 2022 Level 1 Level 2 Level 3 Assets Other assets: Derivatives 30,275 — 30,275 — Total Assets $ 30,275 $ — $ 30,275 $ — Liabilities Derivatives $ (11,624) $ — $ (11,624) $ — Total Liabilities $ (11,624) $ — $ (11,624) $ — (In thousands) Fair Value Measurements at Reporting Date Using Description December 31, 2021 Level 1 Level 2 Level 3 Assets Cash and cash equivalents: Money market funds $ 101,290 $ 101,290 $ — $ — Other assets: Derivatives 12,407 — 12,407 — Total Assets $ 113,697 $ 101,290 $ 12,407 $ — Liabilities Derivatives $ (9,468) $ — $ (9,468) $ — Total Liabilities $ (9,468) $ — $ (9,468) $ —

Derivative instruments and he_2

Derivative instruments and hedging activities (Tables)	9 Months Ended
	Sep. 30, 2022
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Schedule of Forward Contracts Notional Amount	We held forward contracts designated as cash flow hedges with the following notional amounts: (In thousands) US Dollar Equivalent As of September 30, 2022 As of December 31, (Unaudited) 2021 British pound $ 19,480 $ 25,947 Chinese yuan 57,385 99,066 Euro 95,533 145,351 Hungarian forint 29,135 54,939 Japanese yen 21,507 43,128 Korean won 6,316 21,180 Malaysian ringgit 12,717 29,624 Total forward contracts notional amount $ 242,073 $ 419,235
Schedule of Fair Value of Derivative Instruments	The following tables present the fair value of derivative instruments on our Consolidated Balance Sheets at September 30, 2022 and December 31, 2021, respectively. Asset Derivatives September 30, 2022 December 31, 2021 (In thousands) (Unaudited) Balance Sheet Location Fair Value Fair Value Derivatives designated as hedging instruments Foreign exchange contracts - ST forwards Prepaid expenses and other current assets $ 25,122 $ 8,993 Foreign exchange contracts - LT forwards Other long-term assets 241 2,908 Total derivatives designated as hedging instruments $ 25,363 $ 11,901 Derivatives not designated as hedging instruments Foreign exchange contracts - ST forwards Prepaid expenses and other current assets $ 4,912 $ 506 Total derivatives not designated as hedging instruments $ 4,912 $ 506 Total derivatives $ 30,275 $ 12,407 Liability Derivatives September 30, 2022 December 31, 2021 (In thousands) (Unaudited) Balance Sheet Location Fair Value Fair Value Derivatives designated as hedging instruments Foreign exchange contracts - ST forwards Other current liabilities $ (9,414) $ (6,425) Foreign exchange contracts - LT forwards Other long-term liabilities (790) (2,377) Total derivatives designated as hedging instruments $ (10,204) $ (8,802) Derivatives not designated as hedging instruments Foreign exchange contracts - ST forwards Other current liabilities $ (1,420) $ (666) Total derivatives not designated as hedging instruments $ (1,420) $ (666) Total derivatives $ (11,624) $ (9,468)
Schedule of Effect of Derivative Instruments	The following tables present the effect of derivative instruments on our Consolidated Statements of Income for the three months ended September 30, 2022 and 2021, respectively: September 30, 2022 (In thousands) (Unaudited) Derivatives in Cash Flow Hedging Relationship Gain or (Loss) Recognized in OCI on Derivative Location of Gain or (Loss) Reclassified from Accumulated OCI into Income Gain or (Loss) Reclassified from Accumulated OCI into Income Foreign exchange contracts - forwards $ 5,366 Net sales $ 7,347 Foreign exchange contracts - forwards (786) Cost of sales (1,392) Foreign exchange contracts - forwards (620) Operating expenses (929) Total $ 3,960 $ 5,026 September 30, 2021 (In thousands) (Unaudited) Derivatives in Cash Flow Hedging Relationship Gain or (Loss) Recognized in OCI on Derivative Location of Gain or (Loss) Reclassified from Accumulated OCI into Income Gain or (Loss) Reclassified from Accumulated OCI into Income Foreign exchange contracts - forwards $ 7,400 Net sales $ (815) Foreign exchange contracts - forwards (1,869) Cost of sales (73) Foreign exchange contracts - forwards (1,288) Operating expenses (88) Total $ 4,243 $ (976) (In thousands) Derivatives not Designated as Hedging Instruments Location of Gain (Loss) Recognized in Income Amount of Gain (Loss) Recognized in Income Amount of Gain (Loss) Recognized in Income September 30, 2022 September 30, 2021 (Unaudited) (Unaudited) Foreign exchange contracts - forwards Other expense $ 5,622 (1,679) Total $ 5,622 $ (1,679) The following tables present the effect of derivative instruments on our Consolidated Statements of Income for the nine months ended September 30, 2022 and 2021, respectively: September 30, 2022 (In thousands) (Unaudited) Derivatives in Cash Flow Hedging Relationship Gain or (Loss) Recognized in OCI on Derivative Location of Gain or (Loss) Reclassified from Accumulated OCI into Income Gain or (Loss) Reclassified from Accumulated OCI into Income Foreign exchange contracts - forwards $ 17,502 Net sales $ 14,141 Foreign exchange contracts - forwards (3,253) Cost of sales (2,579) Foreign exchange contracts - forwards (2,262) Operating expenses (1,859) Total $ 11,987 $ 9,703 September 30, 2021 (In thousands) (Unaudited) Derivatives in Cash Flow Hedging Relationship Gain or (Loss) Recognized in OCI on Derivative Location of Gain or (Loss) Reclassified from Accumulated OCI into Income Gain or (Loss) Reclassified from Accumulated OCI into Income Foreign exchange contracts - forwards $ 23,098 Net sales $ (5,249) Foreign exchange contracts - forwards (2,675) Cost of sales (73) Foreign exchange contracts - forwards (1,818) Operating expenses (70) Total $ 18,605 $ (5,392) (In thousands) Derivatives not Designated as Hedging Instruments Location of Gain (Loss) Recognized in Income Amount of Gain (Loss) Recognized in Income Amount of Gain (Loss) Recognized in Income September 30, 2022 September 30, 2021 (Unaudited) (Unaudited) Foreign exchange contracts - forwards Other expense $ 8,409 $ (3,942) Total $ 8,409 $ (3,942)

Inventories, net (Tables)

Inventories, net (Tables)	9 Months Ended
	Sep. 30, 2022
Inventory Disclosure [Abstract]
Schedule of Inventories, Net	Inventories, net consist of the following: September 30, 2022 December 31, (In thousands) (Unaudited) 2021 Raw materials $ 253,698 $ 181,676 Work-in-process 14,915 14,573 Finished goods 104,931 92,994 Total $ 373,544 $ 289,243

Intangible assets, net and go_2

Intangible assets, net and goodwill  (Tables)	9 Months Ended
	Sep. 30, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Finite-Lived Intangible Assets	Intangible assets at September 30, 2022 and December 31, 2021 are as follows: September 30, 2022 (In thousands) (Unaudited) December 31, 2021 Gross Carrying Amount Accumulated Amortization Net Carrying Amount Gross Carrying Amount Accumulated Amortization Net Carrying Amount Capitalized software development costs $ 20,964 $ (16,722) $ 4,242 $ 45,671 $ (36,457) $ 9,214 Acquired technology 171,754 (48,108) 123,646 148,155 (34,264) 113,891 Customer relationships 99,780 (28,985) 70,795 93,931 (19,717) 74,214 Patents 37,070 (30,882) 6,188 36,217 (29,316) 6,901 Other 35,539 (20,680) 14,859 32,962 (16,764) 16,198 Total $ 365,107 $ (145,377) $ 219,730 $ 356,936 $ (136,518) $ 220,418
Schedule of Goodwill	The carrying amount of goodwill as of September 30, 2022 was as follows: (In thousands) Amount Balance as of December 31, 2021 $ 575,992 Acquisitions 32,693 Measurement period adjustments 4,243 Foreign currency translation impact (19,780) Balance as of September 30, 2022 (unaudited) $ 593,148

Leases (Tables)

Leases (Tables)	9 Months Ended
	Sep. 30, 2022
Leases [Abstract]
Components of Lease Expense	The components of operating lease expense were as follows (unaudited): Three Months Ended Nine Months Ended (In thousands) September 30, 2022 September 30, 2021 September 30, 2022 September 30, 2021 Operating Lease Cost (1) $ 5,657 $ 5,174 $ 16,561 $ 15,712 (1) Includes variable and short-term lease costs
Schedule of Future Minimum Lease Payments	Maturities of lease liabilities as of September 30, 2022 were as follows (unaudited): (In thousands) Years ending December 31, Operating Leases 2022 (Excluding the nine months ended September 30, 2022) $ 4,601 2023 14,472 2024 11,615 2025 8,164 2026 7,154 Thereafter 2,922 Total future minimum lease payments 48,928 Less imputed interest (3,613) Total lease liabilities $ 45,315

Comprehensive income (Tables)

Comprehensive income (Tables)	9 Months Ended
	Sep. 30, 2022
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]
Schedule of Comprehensive Income (Loss)	The accumulated OCI, net of tax, for the nine months ended September 30, 2022 and 2021, consisted of the following: September 30, 2022 (Unaudited) (In thousands) Currency translation adjustment Investments Derivative instruments Accumulated other comprehensive income/(loss) Balance as of December 31, 2021 $ (23,179) $ — 3,048 $ (20,131) Current-period other comprehensive (loss) income (32,009) — 21,690 (10,319) Reclassified from accumulated OCI into income — — (9,703) (9,703) Income tax expense — — 2,862 2,862 Balance as of September 30, 2022 $ (55,188) $ — $ 12,173 $ (43,015) September 30, 2021 (Unaudited) (In thousands) Currency translation adjustment Investments Derivative instruments Accumulated other comprehensive income/(loss) Balance as of December 31, 2020 $ (10,066) $ (426) (10,334) $ (20,826) Current-period other comprehensive (loss) income (10,585) (162) 13,213 2,466 Reclassified from accumulated OCI into income — — 5,392 5,392 Income tax (expense) benefit — (4) 4,212 4,208 Balance as of September 30, 2021 $ (20,651) $ (584) $ 4,059 $ (17,176)

Authorized shares of common a_2

Authorized shares of common and preferred stock and stock-based compensation plans (Tables)	9 Months Ended
	Sep. 30, 2022
Share-Based Payment Arrangement [Abstract]
Schedule of Key Assumptions to Value Market-based Awards	The key assumptions used in valuing these market-based awards are as follows: Nine Months Ended (unaudited) September 30, 2022 September 30, 2021 Number of simulations 100,000 100,000 Expected volatility 37.81% 40.60% Expected life in years 2.95 years 2.95 years Risk-free interest rate 1.33% 0.21% Dividend yield 2.52% 2.66%

Segment and geographic inform_2

Segment and geographic information (Tables)	9 Months Ended
	Sep. 30, 2022
Segment Reporting [Abstract]
Schedule of Net Sales by Country	The following table presents summarized information for net sales by country. Revenues from external customers are generally attributed to countries based upon the customer's location. Net sales attributable to each individual foreign country outside the U.S. and China were not material. (in millions) United States China (1) Rest of the World Total Net sales: Three months ended September 30, 2022 $ 185 $ 57 $ 186 $ 428 Three months ended September 30, 2021 $ 141 $ 59 $ 167 $ 367 Nine months ended September 30, 2022 $ 489 $ 178 $ 542 $ 1,209 Nine months ended September 30, 2021 $ 388 $ 172 $ 489 $ 1,049 (1): Includes Mainland China and the Hong Kong Special Administrative Region The following table presents summarized information for long-lived assets by country. Long-lived assets attributable to each individual country outside the U.S., Hungary and Malaysia were not material. Long-lived assets consist of property, plant, and equipment and operating lease right-of-use assets excluding intangible assets. (in millions) United States Hungary Malaysia Rest of the World Total Long-lived Assets: September 30, 2022 $ 123 $ 52 $ 82 $ 57 $ 314 December 31, 2021 $ 125 $ 51 $ 76 $ 60 $ 312

Debt (Tables)

Debt (Tables)	9 Months Ended
	Sep. 30, 2022
Debt Disclosure [Abstract]
Schedule of Amounts Outstanding Borrowing Arrangements	The following table presents the amounts outstanding related to our borrowing arrangements discussed above as of September 30, 2022 (unaudited) and December 31, 2021, respectively: September 30, December 31, (in thousands) 2022 2021 Secured Credit Agreement 2022 Term loan (effective interest rate of 4.7%) $ 500,000 $ — 2021 Revolving credit facility (effective interest rate of 4.7%) 70,000 300,000 Total Debt 570,000 300,000 Less: Unamortized debt issuance costs (2,232) — Less: Current portion of total debt (25,000) — Total Debt, non-current $ 542,768 $ 300,000

Commitments and contingencies (

Commitments and contingencies (Tables)	9 Months Ended
	Sep. 30, 2022
Commitments and Contingencies Disclosure [Abstract]
Schedule of Product Warranty Liability	The warranty reserve for the nine months ended September 30, 2022 and 2021 was as follows: Nine Months Ended September 30, (In thousands) (Unaudited) 2022 2021 Balance at the beginning of the period $ 3,210 $ 2,872 Accruals for warranties issued during the period 1,362 2,037 Accruals related to pre-existing warranties (567) (636) Settlements made (in cash or in kind) during the period (1,676) (1,291) Balance at the end of the period $ 2,329 $ 2,982

Restructuring (Tables)

Restructuring (Tables)	9 Months Ended
	Sep. 30, 2022
Restructuring and Related Activities [Abstract]
Summary of Charges Resulting From Restructuring Activities	A summary of the charges in our consolidated statement of operations resulting from our restructuring activities is shown below: Three Months Ended September 30, Nine Months Ended September 30, (In thousands) (Unaudited) (Unaudited) 2022 2021 2022 2021 Cost of sales $ 3,944 $ (7) $ 3,944 $ (50) Research and development 37 65 729 444 Sales and marketing — (223) — 3,924 General and administrative 813 54 813 2,159 Total restructuring and other related costs $ 4,794 $ (111) $ 5,486 $ 6,477
Summary of Balance Sheet Activity Related to Restructuring Activity	A summary of balance sheet activity during 2022 related to our restructuring activity is shown below: (in thousands) Restructuring Liability Balance as of December 31, 2021 $ 11,520 Income statement expense 1,542 Cash payments (10,034) Balance as of September 30, 2022 $ 3,028

Acquisitions (Tables)

Acquisitions (Tables)	9 Months Ended
	Sep. 30, 2022
Business Combination and Asset Acquisition [Abstract]
Schedule of Preliminary Purchase Price Allocation	The information below represents the preliminary purchase price allocation of the TS Business (in thousands): May 2, 2022 Consideration Transferred $ 56,806 Cash and cash equivalents 672 Accounts receivable 3,756 Inventories 5,209 Prepaid expenses and other current assets 1,936 Property and equipment 1,151 Goodwill 19,181 Intangible assets 35,502 Operating lease right-of-use assets 4,642 Other long-term assets 109 Accounts payable and accrued expenses (999) Accrued compensation (464) Operating lease liabilities - current (1,051) Other current liabilities (9,431) Other taxes payable 95 Operating lease liabilities - non-current (3,502) Net Assets Acquired $ 56,806 The information below represents the preliminary purchase price allocation of NHR (in thousands): October 19, 2021 Consideration Transferred $ 205,396 Cash 2,935 Accounts receivable, net 3,902 Inventories, net 4,764 Property and equipment, net 287 Other assets and liabilities (4,621) Intangible assets 98,510 Goodwill 102,090 Accounts payable and accrued expenses (2,186) Deferred revenue (285) Net assets acquired $ 205,396
Summary of Preliminary Purchase Price Allocation and Useful Lives	The following table summarizes the preliminary purchase price allocation and the preliminary average remaining useful lives for identifiable intangible assets acquired. Estimated Fair Value (in thousands) Estimated Useful Lives (in years) Customer relationships $ 5,030 8 Developed software 27,720 5 Trade name contractual rights 2,570 2 Other 182 4-12 Total 35,502 Estimated Fair Value (in thousands) Estimated Useful Lives (in years) Customer relationships $ 54,350 7 Developed software 6,010 2-7 Existing product configurations 28,300 9 In-process research and development (IPR&D) 4,030 Indefinite Trade name 5,820 6 Total $ 98,510
Schedule of Pro Forma Information	The following unaudited pro forma financial information presents combined results of operations for the periods presented, as if the NHR acquisition had occurred on January 1, 2020, with adjustments to give effect to pro forma events that are directly attributable to the acquisition. These pro forma adjustments include additional amortization expense for the identifiable intangible assets and an increase in interest expense related to the additional borrowings entered into in connection with the acquisition, net of tax effects. For the pro forma presentation, given the assumed acquisition date of January 1, 2020, transaction and integration costs that were incurred at or subsequent to the actual acquisition date have been included in the calculation of pro forma net income for the three and nine months ended September 30, 2021, whereas transaction and integration costs that were incurred prior to the acquisition date have been excluded from the calculation of pro forma net income. The unaudited pro forma results are presented for informational purposes only and are not necessarily indicative of what actual results of operations would have been if the acquisition had occurred as the beginning of the period presented, nor are they indicative of future results of operations. The unaudited pro forma results do not include the impact of synergies, nor any potential impacts on current or future market conditions which could alter the unaudited pro forma results. Three months ended September 30, Nine Months Ended September 30, (in thousands) 2021 2021 Net sales $ 376,654 $ 1,075,653 Net income $ 27,460 $ 48,973

Basis of presentation_- Narrati

Basis of presentation - Narrative (Details) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022 USD ($) a	Sep. 30, 2021 USD ($)	Sep. 30, 2022 USD ($) a	Sep. 30, 2021 USD ($)
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Gain on sale of assets | $	$ 33,636	$ 0	$ 33,636	$ 0
Sale
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Gain on sale of assets | $	$ 33,600
Area of property | a	75		75
Office buildings | a	2		2

Basis of presentation - Other E

Basis of presentation - Other Expense, Net (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Interest income	$ 103	$ 56	$ 207	$ 330
Interest expense	(4,851)	(657)	(8,643)	(2,584)
Gain (Loss) from equity-method investments	353	278	483	(5,082)
Net foreign exchange loss	(3,625)	(1,226)	(5,560)	(2,681)
Other gain (loss)	2,870	(271)	4,891	166
Other expense, net	$ (5,150)	$ (1,820)	$ (8,622)	$ (9,851)

Basis of presentation - Schedul

Basis of presentation - Schedule of Other Current Liabilities (Details) - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Income taxes payable - current	$ 17,211	$ 14,457
Hedge payable - current	10,833	7,091
Employer social security taxes - current	0	5,785
Other	24,035	13,338
Other current liabilities	$ 52,079	$ 40,671

Basis of presentation - Sched_2

Basis of presentation - Schedule of Earnings Per Share (Details) - shares shares in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Weighted average shares outstanding - basic (in shares)	132,044	133,031	132,040	132,657
Plus: Common share equivalents
RSUs (in shares)	537	655	961	1,172
Weighted average shares outstanding-diluted (in shares)	132,581	133,686	133,001	133,829
RSU
Plus: Common share equivalents
Anti-dilutive securities excluded from the computation of diluted EPS (in shares)	1,048	143	400	123

Revenue - Disaggregation of Rev

Revenue - Disaggregation of Revenue (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Disaggregation of Revenue [Line Items]
Total net sales	$ 427,928	$ 367,162	$ 1,208,699	$ 1,049,040
Semiconductor & Electronics
Disaggregation of Revenue [Line Items]
Total net sales	101,678	93,892	320,920	292,114
Transportation
Disaggregation of Revenue [Line Items]
Total net sales	83,692	52,954	212,471	149,410
Aerospace, Defense & Government
Disaggregation of Revenue [Line Items]
Total net sales	104,641	92,646	297,569	256,211
Portfolio
Disaggregation of Revenue [Line Items]
Total net sales	137,917	127,670	377,739	351,305
Americas
Disaggregation of Revenue [Line Items]
Total net sales	192,961	148,904	511,348	410,306
EMEA
Disaggregation of Revenue [Line Items]
Total net sales	110,336	94,863	308,494	269,555
APAC
Disaggregation of Revenue [Line Items]
Total net sales	124,631	123,395	388,857	369,179
Point-in-Time
Disaggregation of Revenue [Line Items]
Total net sales	371,667	310,430	1,037,177	884,111
Point-in-Time | Americas
Disaggregation of Revenue [Line Items]
Total net sales	166,318	125,069	432,402	341,870
Point-in-Time | EMEA
Disaggregation of Revenue [Line Items]
Total net sales	91,249	72,430	247,687	204,786
Point-in-Time | APAC
Disaggregation of Revenue [Line Items]
Total net sales	114,100	112,931	357,088	337,455
Over Time
Disaggregation of Revenue [Line Items]
Total net sales	56,261	56,732	171,522	164,929
Over Time | Americas
Disaggregation of Revenue [Line Items]
Total net sales	26,643	23,835	78,946	68,436
Over Time | EMEA
Disaggregation of Revenue [Line Items]
Total net sales	19,087	22,433	60,807	64,769
Over Time | APAC
Disaggregation of Revenue [Line Items]
Total net sales	$ 10,531	$ 10,464	$ 31,769	$ 31,724

Revenue - Change in Unearned Re

Revenue - Change in Unearned Revenue (Details) $ in Thousands	9 Months Ended
	Sep. 30, 2022 USD ($)
Movement in Deferred Revenue [Roll Forward]
Deferred revenue, beginning balance	$ 170,640
Deferral of revenue billed in current period, net of recognition	130,948
Recognition of revenue deferred in prior periods	(118,902)
Foreign currency translation impact	(14,252)
Deferred revenue, ending balance	$ 168,434

Revenue - Narrative (Details)

Revenue - Narrative (Details) $ in Millions	9 Months Ended
	Sep. 30, 2022 USD ($)
Revenue from Contract with Customer [Abstract]
Payment terms	Amounts billed in advance of services being provided are typically accounted for as deferred revenue. Nearly all of our deferred revenue balance is related to extended hardware and software maintenance contracts. Payment terms and conditions vary by contract type, although payment is typically due within 30 to 90 days of contract inception.
Undelivered performance obligation	$ 94
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2022-10-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Remaining performance obligation, percent	12%
Performance obligation, term	3 months
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2023-01-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Remaining performance obligation, percent	42%
Performance obligation, term	1 year
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2024-01-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Remaining performance obligation, percent	46%
Performance obligation, term

Investments (Details)

Investments (Details) - USD ($)	3 Months Ended			9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Mar. 31, 2021	Sep. 30, 2022	Sep. 30, 2021	Dec. 31, 2021
Debt Securities, Available-for-sale [Line Items]
Carrying value of equity method investments	$ 28,000,000			$ 28,000,000		$ 32,000,000
Impairment loss			$ 3,500,000
Equity-Method Investment
Debt Securities, Available-for-sale [Line Items]
Net sales	1,500,000	$ 900,000		4,300,000	$ 2,500,000
Purchase	$ 0	$ 0		$ 0	$ 0

Fair value measurements (Detail

Fair value measurements (Details) - Recurring - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Other assets:
Derivatives	$ 30,275	$ 12,407
Total Assets	30,275	113,697
Derivatives	(11,624)	(9,468)
Total Liabilities	(11,624)	(9,468)
Money market funds
Other assets:
Cash and cash equivalents		101,290
Level 1
Other assets:
Derivatives	0	0
Total Assets	0	101,290
Derivatives	0	0
Total Liabilities	0	0
Level 1 | Money market funds
Other assets:
Cash and cash equivalents		101,290
Level 2
Other assets:
Derivatives	30,275	12,407
Total Assets	30,275	12,407
Derivatives	(11,624)	(9,468)
Total Liabilities	(11,624)	(9,468)
Level 2 | Money market funds
Other assets:
Cash and cash equivalents		0
Level 3
Other assets:
Derivatives	0	0
Total Assets	0	0
Derivatives	0	0
Total Liabilities	$ 0	0
Level 3 | Money market funds
Other assets:
Cash and cash equivalents		$ 0

Derivative instruments and he_3

Derivative instruments and hedging activities - Narrative (Details) $ in Thousands	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2022 USD ($) country	Sep. 30, 2021	Sep. 30, 2022 USD ($) country	Sep. 30, 2021	Dec. 31, 2021 USD ($)
Derivative [Line Items]
Number of countries for which entity has direct operations | country	40		40
Period of protection against the reduction in value caused by a fluctuation, minimum (in number of years)			1 year
Period of protection against the reduction in value caused by a fluctuation, maximum (in number of years)			3 years
Duration of foreign currency forward contracts (or less)			15 months		24 months
Foreign currency forward contracts notional amount	$ 242,073		$ 242,073		$ 419,235
Forward Contracts
Derivative [Line Items]
Duration of time, foreign currency cash flow hedge			40 months
Forward Contracts | Net sales
Derivative [Line Items]
Gains (losses) expected to be reclassified from AOCI to earnings			$ 25,100
Forward Contracts | Cost of sales
Derivative [Line Items]
Gains (losses) expected to be reclassified from AOCI to earnings			(5,400)
Forward Contracts | Operating expenses
Derivative [Line Items]
Gains (losses) expected to be reclassified from AOCI to earnings			$ (4,000)
Forward Contracts | Maximum
Derivative [Line Items]
Percentage of derivative risk hedged	100%		100%
Other Derivatives
Derivative [Line Items]
Foreign currency forward contracts notional amount	$ 124,000		$ 124,000		$ 94,000
Other Derivatives | Maximum
Derivative [Line Items]
Percentage of derivative risk hedged	90%		90%
Duration of foreign currency forward contracts (or less)			90 days
Net sales | Geographic Concentration Risk | Non-Americas
Derivative [Line Items]
Concentration risk	55%	59%	58%	61%

Derivative instruments and he_4

Derivative instruments and hedging activities - Summary Of Notional Amounts Of Derivative Instruments (Details) - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Derivative [Line Items]
Total forward contracts notional amount	$ 242,073	$ 419,235
British pound
Derivative [Line Items]
Total forward contracts notional amount	19,480	25,947
Chinese yuan
Derivative [Line Items]
Total forward contracts notional amount	57,385	99,066
Euro
Derivative [Line Items]
Total forward contracts notional amount	95,533	145,351
Hungarian forint
Derivative [Line Items]
Total forward contracts notional amount	29,135	54,939
Japanese yen
Derivative [Line Items]
Total forward contracts notional amount	21,507	43,128
Korean won
Derivative [Line Items]
Total forward contracts notional amount	6,316	21,180
Malaysian ringgit
Derivative [Line Items]
Total forward contracts notional amount	$ 12,717	$ 29,624

Derivative instruments and he_5

Derivative instruments and hedging activities - Fair Value Of Derivative Instruments On Consolidated Balance Sheets (Details) - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Derivatives, Fair Value [Line Items]
Derivative assets	$ 30,275	$ 12,407
Derivative liability	(11,624)	(9,468)
Derivatives designated as hedging instruments
Derivatives, Fair Value [Line Items]
Derivative assets	25,363	11,901
Derivative liability	(10,204)	(8,802)
Derivatives designated as hedging instruments | Foreign exchange contracts - ST forwards | Prepaid expenses and other current assets
Derivatives, Fair Value [Line Items]
Derivative assets	25,122	8,993
Derivatives designated as hedging instruments | Foreign exchange contracts - ST forwards | Other current liabilities
Derivatives, Fair Value [Line Items]
Derivative liability	(9,414)	(6,425)
Derivatives designated as hedging instruments | Foreign exchange contracts - LT forwards | Other long-term assets
Derivatives, Fair Value [Line Items]
Derivative assets	241	2,908
Derivatives designated as hedging instruments | Foreign exchange contracts - LT forwards | Other long-term liabilities
Derivatives, Fair Value [Line Items]
Derivative liability	(790)	(2,377)
Derivatives not designated as hedging instruments
Derivatives, Fair Value [Line Items]
Derivative assets	4,912	506
Derivative liability	(1,420)	(666)
Derivatives not designated as hedging instruments | Foreign exchange contracts - ST forwards | Prepaid expenses and other current assets
Derivatives, Fair Value [Line Items]
Derivative assets	4,912	506
Derivatives not designated as hedging instruments | Foreign exchange contracts - ST forwards | Other current liabilities
Derivatives, Fair Value [Line Items]
Derivative liability	$ (1,420)	$ (666)

Derivative instruments and he_6

Derivative instruments and hedging activities - Effect Of Derivative Instruments On Consolidated Statements Of Income (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Derivatives designated as hedging instruments
Derivative Instruments, Gain (Loss) [Line Items]
Gain or (Loss) Recognized in OCI on Derivative	$ 3,960	$ 4,243	$ 11,987	$ 18,605
Gain or (Loss) Reclassified from Accumulated OCI into Income	5,026	(976)	9,703	(5,392)
Derivatives designated as hedging instruments | Foreign exchange contracts - forwards | Net sales
Derivative Instruments, Gain (Loss) [Line Items]
Gain or (Loss) Reclassified from Accumulated OCI into Income	7,347	(815)	14,141	(5,249)
Derivatives designated as hedging instruments | Foreign exchange contracts - forwards | Cost of sales
Derivative Instruments, Gain (Loss) [Line Items]
Gain or (Loss) Reclassified from Accumulated OCI into Income	(1,392)	(73)	(2,579)	(73)
Derivatives designated as hedging instruments | Foreign exchange contracts - forwards | Operating expenses
Derivative Instruments, Gain (Loss) [Line Items]
Gain or (Loss) Reclassified from Accumulated OCI into Income	(929)	(88)	(1,859)	(70)
Derivatives designated as hedging instruments | Foreign Exchange Forward A
Derivative Instruments, Gain (Loss) [Line Items]
Gain or (Loss) Recognized in OCI on Derivative	5,366	7,400	17,502	23,098
Derivatives designated as hedging instruments | Foreign Exchange Forward B
Derivative Instruments, Gain (Loss) [Line Items]
Gain or (Loss) Recognized in OCI on Derivative	(786)	(1,869)	(3,253)	(2,675)
Derivatives designated as hedging instruments | Foreign Exchange Forward C
Derivative Instruments, Gain (Loss) [Line Items]
Gain or (Loss) Recognized in OCI on Derivative	(620)	(1,288)	(2,262)	(1,818)
Derivatives not designated as hedging instruments
Derivative Instruments, Gain (Loss) [Line Items]
Amount of Gain (Loss) Recognized in Income	5,622	(1,679)	8,409	(3,942)
Derivatives not designated as hedging instruments | Foreign exchange contracts - forwards | Other expense
Derivative Instruments, Gain (Loss) [Line Items]
Amount of Gain (Loss) Recognized in Income	$ 5,622	$ (1,679)	$ 8,409	$ (3,942)

Inventories, net (Details)

Inventories, net (Details) - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Inventory Disclosure [Abstract]
Raw materials	$ 253,698	$ 181,676
Work-in-process	14,915	14,573
Finished goods	104,931	92,994
Total	$ 373,544	$ 289,243

Intangible assets, net and go_3

Intangible assets, net and goodwill - Schedule Of Finite-Lived Intangible Assets (Details) - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	$ 365,107	$ 356,936
Accumulated Amortization	(145,377)	(136,518)
Net Carrying Amount	219,730	220,418
Capitalized software development costs
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	20,964	45,671
Accumulated Amortization	(16,722)	(36,457)
Net Carrying Amount	4,242	9,214
Acquired technology
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	171,754	148,155
Accumulated Amortization	(48,108)	(34,264)
Net Carrying Amount	123,646	113,891
Customer relationships
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	99,780	93,931
Accumulated Amortization	(28,985)	(19,717)
Net Carrying Amount	70,795	74,214
Patents
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	37,070	36,217
Accumulated Amortization	(30,882)	(29,316)
Net Carrying Amount	6,188	6,901
Other
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	35,539	32,962
Accumulated Amortization	(20,680)	(16,764)
Net Carrying Amount	$ 14,859	$ 16,198

Intangible assets, net and go_4

Intangible assets, net and goodwill - Narrative (Details)	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2022 USD ($)	Sep. 30, 2021 USD ($)	Sep. 30, 2022 USD ($) segment	Sep. 30, 2021 USD ($)	Dec. 31, 2021 USD ($)
Finite-Lived Intangible Assets [Line Items]
Amortization of intangible assets	$ 14,300,000	$ 13,400,000	$ 41,500,000	$ 43,300,000
Number of operating segments | segment			1
Goodwill impairment			$ 0		$ 0
Capitalized software development costs | Minimum
Finite-Lived Intangible Assets [Line Items]
Intangible assets amortization period (in years)			3 years
Capitalized software development costs | Maximum
Finite-Lived Intangible Assets [Line Items]
Intangible assets amortization period (in years)			6 years
Acquired technology | Minimum
Finite-Lived Intangible Assets [Line Items]
Intangible assets amortization period (in years)			5 years
Acquired technology | Maximum
Finite-Lived Intangible Assets [Line Items]
Intangible assets amortization period (in years)			10 years
Customer relationships | Minimum
Finite-Lived Intangible Assets [Line Items]
Intangible assets amortization period (in years)			5 years
Customer relationships | Maximum
Finite-Lived Intangible Assets [Line Items]
Intangible assets amortization period (in years)			10 years
Other | Minimum
Finite-Lived Intangible Assets [Line Items]
Intangible assets amortization period (in years)			5 years
Other | Maximum
Finite-Lived Intangible Assets [Line Items]
Intangible assets amortization period (in years)			10 years
Patents | Minimum
Finite-Lived Intangible Assets [Line Items]
Intangible assets amortization period (in years)			10 years
Patents | Maximum
Finite-Lived Intangible Assets [Line Items]
Intangible assets amortization period (in years)			17 years

Intangible assets, net and go_5

Intangible assets, net and goodwill - Schedule of Goodwill (Details) $ in Thousands	9 Months Ended
	Sep. 30, 2022 USD ($)
Goodwill [Roll Forward]
Balance at beginning of period	$ 575,992
Acquisitions	32,693
Measurement period adjustments	4,243
Foreign currency translation impact	(19,780)
Balance at end of period	$ 593,148

Leases - Summary of Components

Leases - Summary of Components of Lease Expense and Other Information (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Lessee, Lease, Description [Line Items]
Option to terminate period			1 year
Operating Lease Cost	$ 5,657	$ 5,174	$ 16,561	$ 15,712
Minimum
Lessee, Lease, Description [Line Items]
Remaining term	1 year		1 year
Maximum
Lessee, Lease, Description [Line Items]
Remaining term	92 years		92 years
Option to extend term	9 years		9 years

Leases - Maturities of Lease Li

Leases - Maturities of Lease Liabilities (Details) $ in Thousands	Sep. 30, 2022 USD ($)
Leases [Abstract]
2022 (Excluding the nine months ended September 30, 2022)	$ 4,601
2023	14,472
2024	11,615
2025	8,164
2026	7,154
Thereafter	2,922
Total future minimum lease payments	48,928
Less imputed interest	(3,613)
Total lease liabilities	$ 45,315

Income taxes (Details)

Income taxes (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021	Dec. 31, 2021
Operating Loss Carryforwards [Line Items]
Valuation allowance	$ 84,000,000		$ 84,000,000		$ 84,000,000
Unrecognized tax benefits	11,900,000		11,900,000		$ 9,400,000
Gross increase in unrecognized tax benefits, current period	1,200,000
Reasonable possibility of future tax benefits	1,500,000		1,500,000
Interest expense related to uncertain tax positions	40,000
Accrued interest related to uncertain tax positions	$ 400,000		$ 400,000
Effective income tax rate	18%	16%	19%	16%
Income tax benefit of tax holiday (in usd per share)		$ 0.01		$ 0.01
Hungary
Operating Loss Carryforwards [Line Items]
Income tax benefit in foreign tax position	$ 3,000,000	$ 1,900,000	$ 5,900,000	$ 2,200,000
Malaysia
Operating Loss Carryforwards [Line Items]
Income tax benefit of tax holiday, amount	$ 500,000	$ 600,000	$ 1,600,000	$ 900,000
Income tax benefit of tax holiday (in usd per share)	$ 0.01		$ 0.01

Comprehensive income (Details)

Comprehensive income (Details) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning Balance	$ 1,223,697	$ 1,224,871
Current-period other comprehensive (loss) income	(10,319)	2,466
Reclassified from accumulated OCI into income	(9,703)	5,392
Income tax (expense) benefit	2,862	4,208
Ending Balance	1,123,485	1,226,472
Currency translation adjustment
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning Balance	(23,179)	(10,066)
Current-period other comprehensive (loss) income	(32,009)	(10,585)
Reclassified from accumulated OCI into income	0	0
Income tax (expense) benefit	0	0
Ending Balance	(55,188)	(20,651)
Investments
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning Balance	0	(426)
Current-period other comprehensive (loss) income	0	(162)
Reclassified from accumulated OCI into income	0	0
Income tax (expense) benefit	0	(4)
Ending Balance	0	(584)
Derivative instruments
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning Balance	3,048	(10,334)
Current-period other comprehensive (loss) income	21,690	13,213
Reclassified from accumulated OCI into income	(9,703)	5,392
Income tax (expense) benefit	2,862	4,212
Ending Balance	12,173	4,059
Accumulated other comprehensive income/(loss)
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning Balance	(20,131)	(20,826)
Ending Balance	$ (43,015)	$ (17,176)

Authorized shares of common a_3

Authorized shares of common and preferred stock and stock-based compensation plans - Narrative (Details) - USD ($)

3 Months Ended

9 Months Ended

May 10, 2022

Jan. 01, 2022

Jan. 01, 2021

May 05, 2020

May 12, 2015

May 11, 2010

Sep. 30, 2022

Sep. 30, 2021

Sep. 30, 2022

Sep. 30, 2021

Mar. 31, 2022

Jan. 19, 2022

Dec. 31, 2021

Oct. 23, 2019

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Common and preferred stock shares authorized (in shares)

365,000,000

365,000,000

Preferred stock, authorized (in shares)

5,000,000

5,000,000

5,000,000

Preferred stock, par value per share (in usd per share)

$ 0.01

$ 0.01

$ 0.01

Common stock, authorized (in shares)

360,000,000

360,000,000

360,000,000

Common stock, par value per share (in usd per share)

$ 0.01

$ 0.01

$ 0.01

Common stock repurchased (in shares)

3,792,063

Common stock repurchased, average cost per share (in usd per share)

$ 40.04

2022 Program

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Board of Directors approved stock repurchase (up to)

$ 250,000,000

Authorized common stock available for repurchase Amount

$ 109,000,000

$ 109,000,000

Common stock repurchased (in shares)

2,033,135

Common stock repurchased, average cost per share (in usd per share)

$ 40.25

2019 Program

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Authorized common stock available for repurchase (in shares)

0

3,000,000

Common stock repurchased (in shares)

599,066

599,066

Common stock repurchased, average cost per share (in usd per share)

$ 41.73

$ 41.73

Performance Shares

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Performance-based stock units, weighted average grant date fair value (in usd per share)

$ 59.65

$ 66.97

$ 59.65

$ 66.97

2010 Plan

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Common stock, authorized (in shares)

3,000,000

Number of shares reserved for issuance (in shares)

2,518,416

2010 Plan | Vesting period one

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Award vesting period (in years)

3 years

2010 Plan | Vesting period two

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Award vesting period (in years)

5 years

2010 Plan | Vesting period three

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Award vesting period (in years)

10 years

1994 and 2005 Plans

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Number of shares reserved for issuance (in shares)

3,362,304

2015 Plans

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Number of shares reserved for issuance (in shares)

567,142

3,000,000

Shares available for grant under stock plan (in shares)

567,142

2015 Plans | Vesting period one

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Award vesting period (in years)

3 years

2015 Plans | Vesting period two

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Award vesting period (in years)

4 years

2015 Plans | Vesting period three

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Award vesting period (in years)

5 years

2015 Plans | Vesting period four

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Award vesting period (in years)

10 years

2020 Plan

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Number of shares reserved for issuance (in shares)

4,500,000

Shares available for grant under stock plan (in shares)

1,568,571

2020 Plan | Minimum

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Percentage of target shares granted

0%

2020 Plan | Maximum

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Percentage of target shares granted

200%

2020 Plan | Performance Shares

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Performance-based stock units, vested in period (in shares)

164,843

130,006

Performance period

3 years

3 years

3 years

2020 Plan | Vesting period one

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Award vesting period (in years)

1 year

2020 Plan | Vesting period two

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Award vesting period (in years)

2 years

2020 Plan | Vesting period three

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Award vesting period (in years)

3 years

2020 Plan | Vesting period four

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Award vesting period (in years)

4 years

ESPP

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Shares available for grant under stock plan (in shares)

3,000,000

Percentage of the lower of the market related to purchase of common stock

85%

85%

Maximum employee subscription rate

15%

15%

Common stock reserved for future issuance under employee stock purchase plan (in shares)

4,270,314

4,270,314

Shares issued under employee stock purchase plan (in shares)

791,207

Weighted average purchase price of employees' purchase rights (in usd per share)

$ 32.16

2022 Plan

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Number of shares reserved for issuance (in shares)

4,500,000

Shares available for grant under stock plan (in shares)

6,042,755

6,042,755

2022 Plan | Vesting period one

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Award vesting period (in years)

1 year

2022 Plan | Vesting period two

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Award vesting period (in years)

2 years

2022 Plan | Vesting period three

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Award vesting period (in years)

3 years

2022 Plan | Vesting period four

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Award vesting period (in years)

4 years

Authorized shares of common a_4

Authorized shares of common and preferred stock and stock-based compensation plans - Schedule of Key Assumptions to Value Market-based Awards (Details) - Performance Shares - simulation simulation in Thousands	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of simulations	100	100
Expected volatility	37.81%	40.60%
Expected life in years	2 years 11 months 12 days	2 years 11 months 12 days
Risk-free interest rate	1.33%	0.21%
Dividend yield	2.52%	2.66%

Segment and geographic inform_3

Segment and geographic information - Narrative (Details)	9 Months Ended
	Sep. 30, 2022 segment region
Segment Reporting [Abstract]
Number of operating segments | segment	1
Number of geographic regions company operates in | region	3

Segment and geographic inform_4

Segment and geographic information - Schedule of Net Sales by Country (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021	Dec. 31, 2021
Revenues from External Customers and Long-Lived Assets [Line Items]
Total revenue	$ 427,928	$ 367,162	$ 1,208,699	$ 1,049,040
Long-lived assets	314,000		314,000		$ 312,000
United States
Revenues from External Customers and Long-Lived Assets [Line Items]
Total revenue	185,000	141,000	489,000	388,000
Long-lived assets	123,000		123,000		125,000
China
Revenues from External Customers and Long-Lived Assets [Line Items]
Total revenue	57,000	59,000	178,000	172,000
Hungary
Revenues from External Customers and Long-Lived Assets [Line Items]
Long-lived assets	52,000		52,000		51,000
Malaysia
Revenues from External Customers and Long-Lived Assets [Line Items]
Long-lived assets	82,000		82,000		76,000
Rest of the World
Revenues from External Customers and Long-Lived Assets [Line Items]
Total revenue	186,000	$ 167,000	542,000	$ 489,000
Long-lived assets	$ 57,000		$ 57,000		$ 60,000

Debt - Schedule of Amounts Outs

Debt - Schedule of Amounts Outstanding Borrowing Arrangements (Details) - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Debt Instrument [Line Items]
Less: Current portion of total debt	$ (25,000)	$ 0
Total Debt, non-current	542,768	300,000
Line of Credit
Debt Instrument [Line Items]
Total Debt	570,000	300,000
Less: Unamortized debt issuance costs	(2,232)	0
Less: Current portion of total debt	(25,000)	0
Total Debt, non-current	$ 542,768	300,000
2022 Term loan | Term Loan
Debt Instrument [Line Items]
Effective interest rate	4.70%
Total Debt	$ 500,000	0
2021 Revolving credit facility | Secured Revolving Loan Facility
Debt Instrument [Line Items]
Effective interest rate	4.70%
Total Debt	$ 70,000	$ 300,000

Debt - Narrative (Details)

Debt - Narrative (Details) - Third Amended and Restated Credit Agreement - USD ($)	Aug. 24, 2022	Sep. 30, 2022
Line of Credit
Line of Credit Facility [Line Items]
Unsecured revolving line of credit	$ 1,000,000,000
Total leverage ratio	3.50
Leverage ratio for material acquisitions	4
Minimum consolidated interest coverage ratio	3
Line of Credit | Minimum
Line of Credit Facility [Line Items]
Quarterly commitment fee	0.15%
Line of Credit | Maximum
Line of Credit Facility [Line Items]
Quarterly commitment fee	0.25%
Line of Credit | Federal funds rate
Line of Credit Facility [Line Items]
Variable interest rate spread	0.50%
Line of Credit | SOFR
Line of Credit Facility [Line Items]
Variable interest rate spread	1%
Line of Credit | SOFR Margin | Minimum
Line of Credit Facility [Line Items]
Variable interest rate spread	0.25%
Line of Credit | SOFR Margin | Maximum
Line of Credit Facility [Line Items]
Variable interest rate spread	0.75%
Line of Credit | SOFR Plus Margin | Minimum
Line of Credit Facility [Line Items]
Variable interest rate spread	1.25%
Line of Credit | SOFR Plus Margin | Maximum
Line of Credit Facility [Line Items]
Variable interest rate spread	1.75%
Line of Credit | LIBOR | Minimum
Line of Credit Facility [Line Items]
Default interest rate	2%
Secured Revolving Loan Facility
Line of Credit Facility [Line Items]
Debt issuance costs		$ 2,200,000
Unsecured revolving line of credit	$ 500,000,000
Term Loan
Line of Credit Facility [Line Items]
Debt issuance costs		$ 2,200,000
Unsecured revolving line of credit	$ 500,000,000
Amortization rate percentage	1.25%
Letter of Credit
Line of Credit Facility [Line Items]
Unsecured revolving line of credit	$ 25,000,000

Commitments and contingencies -

Commitments and contingencies - Narrative (Details) - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2022	Dec. 31, 2021
Commitments and Contingencies Disclosure [Abstract]
Limited warranty on products (in number of years)	1 year
Noncancellable unconditional purchase obligations	$ 20.9	$ 11.7

Commitments and contingencies_2

Commitments and contingencies - Schedule Of Warranty Reserve (Details) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Movement in Standard Product Warranty Accrual [Roll Forward]
Balance at the beginning of the period	$ 3,210	$ 2,872
Accruals for warranties issued during the period	1,362	2,037
Accruals related to pre-existing warranties	(567)	(636)
Settlements made (in cash or in kind) during the period	(1,676)	(1,291)
Balance at the end of the period	$ 2,329	$ 2,982

Restructuring - Narrative (Deta

Restructuring - Narrative (Details) $ in Millions	3 Months Ended
	Sep. 30, 2022 USD ($)
Restructuring and Related Activities [Abstract]
Severance costs	$ 1
Inventory write-down	3.9
Restructuring liability	$ 3

Restructuring - Summary of Char

Restructuring - Summary of Charges in Consolidated Statement of Operations (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Restructuring Cost and Reserve [Line Items]
Total restructuring and other related costs	$ 4,794	$ (111)	$ 5,486	$ 6,477
Cost of sales
Restructuring Cost and Reserve [Line Items]
Total restructuring and other related costs	3,944	(7)	3,944	(50)
Research and development
Restructuring Cost and Reserve [Line Items]
Total restructuring and other related costs	37	65	729	444
Sales and marketing
Restructuring Cost and Reserve [Line Items]
Total restructuring and other related costs	0	(223)	0	3,924
General and administrative
Restructuring Cost and Reserve [Line Items]
Total restructuring and other related costs	$ 813	$ 54	$ 813	$ 2,159

Restructuring - Summary of Bala

Restructuring - Summary of Balance Sheet Activity (Details) $ in Thousands	9 Months Ended
	Sep. 30, 2022 USD ($)
Restructuring Reserve [Roll Forward]
Restructuring reserve, beginning balance	$ 11,520
Income statement expense	1,542
Cash payments	(10,034)
Restructuring reserve, ending balance	$ 3,028

Acquisitions - Narrative (Detai

Acquisitions - Narrative (Details) - USD ($) $ in Thousands				1 Months Ended	3 Months Ended			9 Months Ended
	May 02, 2022	Feb. 28, 2022	Oct. 19, 2021	Oct. 31, 2021	Jun. 30, 2022	Mar. 31, 2022	Jun. 30, 2021	Sep. 30, 2022	Sep. 30, 2021	Dec. 31, 2021
Business Acquisition [Line Items]
Goodwill								$ 593,148		$ 575,992
Proceeds from term loan								500,000	$ 0
Term loan facility | Wells Fargo Securities, LLC | Line of Credit
Business Acquisition [Line Items]
Proceeds from term loan				$ 200,000
T S Business
Business Acquisition [Line Items]
Percentage of voting interests acquired	100%
Cash consideration	$ 56,806
Cash acquired from acquisition	700
Transaction costs								$ 2,200
Goodwill	19,181
Intangible assets	$ 35,502
T S Business | Developed software | Minimum
Business Acquisition [Line Items]
Estimated Useful Lives (in years)	5 years
T S Business | Developed software | Maximum
Business Acquisition [Line Items]
Estimated Useful Lives (in years)	8 years
Heinzinger
Business Acquisition [Line Items]
Cash consideration		$ 22,500
Goodwill		14,000
Intangible assets		$ 7,000
NHR
Business Acquisition [Line Items]
Percentage of voting interests acquired			100%
Cash consideration			$ 205,396
Cash acquired from acquisition			3,000
Transaction costs										$ 6,000
Goodwill			102,090
Intangible assets			$ 98,510
Increase to the fair value of acquired liabilities						$ 5,100
Net decrease in total consideration transferred					$ 800
NHR | Developed software | Minimum
Business Acquisition [Line Items]
Estimated Useful Lives (in years)			2 years
NHR | Developed software | Maximum
Business Acquisition [Line Items]
Estimated Useful Lives (in years)			7 years
Other Acquisitions
Business Acquisition [Line Items]
Cash consideration							$ 20,000
Goodwill							17,000
Intangible assets							$ 4,000

Acquisitions - Schedule of Prel

Acquisitions - Schedule of Preliminary Purchase Price Allocation (Details) - USD ($) $ in Thousands	May 02, 2022	Oct. 19, 2021	Sep. 30, 2022	Dec. 31, 2021
Business Acquisition [Line Items]
Goodwill			$ 593,148	$ 575,992
T S Business
Business Acquisition [Line Items]
Consideration Transferred	$ 56,806
Cash	672
Accounts receivable, net	3,756
Inventories, net	5,209
Prepaid expenses and other current assets	1,936
Property and equipment, net	1,151
Goodwill	19,181
Intangible assets	35,502
Operating lease right-of-use assets	4,642
Other long-term assets	109
Accounts payable and accrued expenses	(999)
Accrued compensation	(464)
Operating lease liabilities - current	(1,051)
Other current liabilities	(9,431)
Other taxes payable	95
Operating lease liabilities - non-current	(3,502)
Net assets acquired	$ 56,806
NHR
Business Acquisition [Line Items]
Consideration Transferred		$ 205,396
Cash		2,935
Accounts receivable, net		3,902
Inventories, net		4,764
Property and equipment, net		287
Other assets and liabilities		(4,621)
Goodwill		102,090
Intangible assets		98,510
Accounts payable and accrued expenses		(2,186)
Deferred revenue		(285)
Net assets acquired		$ 205,396

Acquisitions - Summary of Preli

Acquisitions - Summary of Preliminary Purchase Price Allocation and Useful Lives (Details) - USD ($) $ in Thousands	May 02, 2022	Oct. 19, 2021
T S Business
Business Acquisition [Line Items]
Estimated Fair Value (in thousands)	$ 35,502
T S Business | Customer relationships
Business Acquisition [Line Items]
Estimated Fair Value (in thousands)	$ 5,030
T S Business | Customer relationships | Minimum
Business Acquisition [Line Items]
Estimated Useful Lives (in years)	8 years
T S Business | Developed software
Business Acquisition [Line Items]
Estimated Fair Value (in thousands)	$ 27,720
T S Business | Developed software | Minimum
Business Acquisition [Line Items]
Estimated Useful Lives (in years)	5 years
T S Business | Developed software | Maximum
Business Acquisition [Line Items]
Estimated Useful Lives (in years)	8 years
T S Business | Trade name contractual rights
Business Acquisition [Line Items]
Estimated Fair Value (in thousands)	$ 2,570
Estimated Useful Lives (in years)	2 years
T S Business | Other
Business Acquisition [Line Items]
Estimated Fair Value (in thousands)	$ 182
T S Business | Other | Minimum
Business Acquisition [Line Items]
Estimated Useful Lives (in years)	4 years
T S Business | Other | Maximum
Business Acquisition [Line Items]
Estimated Useful Lives (in years)	12 years
NHR
Business Acquisition [Line Items]
Total		$ 98,510
NHR | In-process research and development (IPR&D)
Business Acquisition [Line Items]
Estimated Fair Value (in thousands)		4,030
NHR | Customer relationships
Business Acquisition [Line Items]
Estimated Fair Value (in thousands)		$ 54,350
Estimated Useful Lives (in years)		7 years
NHR | Developed software
Business Acquisition [Line Items]
Estimated Fair Value (in thousands)		$ 6,010
NHR | Developed software | Minimum
Business Acquisition [Line Items]
Estimated Useful Lives (in years)		2 years
NHR | Developed software | Maximum
Business Acquisition [Line Items]
Estimated Useful Lives (in years)		7 years
NHR | Existing product configurations
Business Acquisition [Line Items]
Estimated Fair Value (in thousands)		$ 28,300
Estimated Useful Lives (in years)		9 years
NHR | Trade name
Business Acquisition [Line Items]
Estimated Fair Value (in thousands)		$ 5,820
Estimated Useful Lives (in years)		6 years

Acquisitions - Pro Forma Inform

Acquisitions - Pro Forma Information (Details) - NHR - USD ($) $ in Thousands	3 Months Ended	9 Months Ended
	Sep. 30, 2021	Sep. 30, 2021
Business Acquisition [Line Items]
Net sales	$ 376,654	$ 1,075,653
Net income	$ 27,460	$ 48,973

Subsequent events (Details)

Subsequent events (Details) - $ / shares		3 Months Ended		9 Months Ended
	Oct. 19, 2022	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Subsequent Event [Line Items]
Dividends declared per share (in usd per share)		$ 0.28	$ 0.27	$ 0.84	$ 0.81
Subsequent event
Subsequent Event [Line Items]
Dividends declared per share (in usd per share)	$ 0.28